SlideShare a Scribd company logo
1 of 40
Download to read offline
2,3,7,8-TETRACHLORODIBENZO-
                                para-DIOXIN,
     2,3,4,7,8-PENTACHLORODIBENZOFURAN,
      AND 3,3′,4,4′,5-PENTACHLOROBIPHENYL
Two of these agents (2,3,7,8-tetrachlorodibenzo-para-dioxin and 2,3,4,7,8-pentachloro-
dibenzofuran were specifically considered by previous IARC Working Groups in 1977, 1987,
and 1997 (IARC, 1977, 1987, 1997). The Working Group in 1987 reviewed polychlorinated
biphenyls, but did not specifically consider 3,3′,4,4′,5-pentachlorobiphenyl. Since the
previous evaluations new data have become available, which have been incorporated in
this Monograph and taken into consideration in the present evaluation.



1.	 Exposure Data                                    Description: Colourless to white crystalline
                                                     solid
                                                     Solubility: Insoluble in water; slightly
1.1	 Identification of the agents                    soluble in n-octanol and methanol; and
   From NTP (2006a, b, c)                            soluble in other organic solvents (e.g.
                                                     dichlorobenzene, chlorobenzene, benzene,
1.1.1	2,3,7,8-Tetrachlorodibenzo-para-dioxin         chloroform, and acetone)
      (2,3,7,8-TCDD, TCDD)                           Octanol/water partition coefficient:
    Chem. Abstr. Serv. Reg. No.: 1746-01-6           log Kow, 6.80
    Chem. Abstr. Serv. Name:
    2,3,7,8-Tetrachlorodibenzo[b,e][1,4]dioxin   1.1.2	2,3,4,7,8-pentachlorodibenzofuran
    Synonyms: 2,3,7,8-TCDD; TCDD; dioxin;              (2,3,4,7,8-PeCDF)
    tetradioxin                                      Chem. Abstr. Serv. Reg. No.: 57117-31-4
    Cl              O             Cl                 Chem. Abstr. Serv. Name:
                                                     2,3,4,7,8-Pentachlorodibenzofuran
                                                     Synonym: 2,3,4,7,8-PeCDF;
    Cl              O             Cl                 2,3,4,7,8-penta-CDF

    C12H4Cl4O2
    Relative molecular mass: 321.98

                                                                                                1
IARC MONOGRAPHS – 100F


                    Cl                           1.2	Occurrence and use
          Cl             O              Cl           2,3,7,8-Tetrachlorodibenzo-para-dioxin
                                                 (TCDD) has no known commercial applications.
                                                 It occurred as a contaminant in chlorophenoxy
          Cl                            Cl
                                                 herbicides, including 2,4,5-trichlorophenoxy-
    C12H3Cl5O                                    acetic acid (2,4,5-T), which were widely used
    Relative molecular mass: 340.42              in the 1960s and 1970s to control weeds (e.g.
    Description: Solid with a melting point of   on pastureland and food crops) and as a defo-
    195–196 °C (NTP Chemical Repository          liant during the Viet Nam war. It is used as a
    Information). It is stable under normal      research chemical and was tested, but never used
    laboratory conditions.                       commercially, as a flame-proofing agent and as
    Solubility in water: 2.36 × 10−4 mg/L at     a pesticide against insects and wood-destroying
    22.7 °C                                      fungi (NTP, 2004).
    Octanol/water partition coefficient:             Polychlorinated dibenzofurans (PCDFs) are
    log Kow, 6.92                                not manufactured commercially other than for
                                                 scientific research purposes. Release of PCDF
                                                 into the environment is mainly from combus-
1.1.3	3,3′,4,4′,5-pentachlorobiphenyl
                                                 tion and incineration. Based on congener-
      (PCB 126)
                                                 specific profiles, combustion sources all produce
    Chem. Abstr. Serv. Reg. No.: 57465-28-8      2,3,7,8-substituted polychlorinated dibenzo-
    Chem. Abstr. Serv. Name:                     para-dioxins (PCDDs) and PCDFs, including
    3,3′,4,4′,5-Pentachlorobiphenyl              2,3,4,7,8-pentachlorodibenzofuran (PeCDF). The
    Synonym: PCB 126                             latter substance is the major congener emitted
               Cl
                                                 from cement kilns burning hazardous waste
                                                 (approximately 20% of the total congener emis-
                                                 sion). Other major sources of PeCDF are metal
     Cl                            Cl            smelting, refining, and processing; chemical
                                                 manufacturing/processing (production of chlo-
               Cl             Cl                 rophenols, PCBs, vinyl chloride); pulp bleaching;
                                                 and existing reservoirs that reflect past releases
    C12H5Cl5                                     (IARC, 1997; USEPA, 2000a).
    Relative molecular mass: 326.42                  Mixtures of polychlorobiphenyls (PCBs),
    Description: Solid with a melting point of   including 3,3′,4,4′,5-pentachlorobiphenyl (PCB
    160–161 °C.                                  126), were produced for commercial purposes
    Solubility in water: 1.03 × 10−3 mg/L at     during the period 1929–1977 for the electrical
    25 °C                                        industry, to be used as dielectric insulating
    Octanol/water partition coefficient:         fluids for transformers and capacitors. PCBs
    log Kow, 6.89                                were also used in hydraulic fluids, plastics, and
                                                 paints. The manufacture and use of PCBs in
                                                 the United States was stopped in 1977 in view
                                                 of increasing amounts of PCB residues in the
                                                 environment that had accumulated during the
                                                 previous decades. However, PCBs continue to be

2
2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126


released into the environment through the use         lipid]. Available data suggest that these levels have
and disposal of products containing PCBs, as          decreased three- to fivefold since the late 1970s,
by-products during the manufacture of certain         when the development of gas chromatography/
organic chemicals, and during combustion of           mass spectrometry methodology permitted
some waste materials (USEPA, 2000a). Due to           these extremely low concentrations of TCDD in
their lipophilic nature (log Kow, 6.5–7.7) and        tissues and in the environment to be measured
resistance to biodegradation, specific PCBs bio-      accurately for the first time. Similarly, since the
concentrate and bio-accumulate in the environ-        mid-1980s, mean tissue concentrations of total
ment. PCBs are widespread in their distribution       TCDD in the general population have decreased
and are found in virtually all environmental          by two- to threefold. Human exposures related
compartments including air, soil, water, sedi-        to occupation or accidents have led to tissue
ment, and biota (USEPA, 2000b).                       concentrations of TCDD up to several orders
                                                      of magnitude higher than background levels
                                                      (IARC, 1997).
1.3	Human exposure
     Polychlorinated        dibenzo-para-dioxins      1.3.1 Occupational exposure to dioxins
(PCDDs), including TCDD, are formed as inad-
                                                          Because TCDD has never been intentionally
vertent by-products during the production of
                                                      manufactured for large-scale commercial use,
chlorophenols and chlorophenoxy herbicides,
                                                      estimates of the numbers of workers exposed in
and have been detected as contaminants in
                                                      the past are not available. From the US National
these products. TCDD may also be produced
                                                      Occupational Exposure Survey (1981–1983), it
in thermal processes such as incineration, in
                                                      was estimated that approximately 14 workers
metal-processing, and in the bleaching of paper
                                                      were potentially exposed to TCDD in the USA
pulp with free chlorine. The relative amounts of
                                                      (NIOSH, 1990). Historical occupational expo-
the TCDD congeners produced depend on the
                                                      sures to TCDD have been reviewed (IARC, 1997).
production or incineration process and vary
                                                          In a series of studies, Collins et al. (2006,
widely (IARC, 1997).
                                                      2007, 2008) examined concentrations of TCDD
     PCDDs are ubiquitous in soil, sediments and
                                                      in serum from 375 workers in Michigan who had
air. Excluding occupational or accidental expo-
                                                      been exposed in the past (26–62 years before)
sures, most human exposure to TCDD occurs
                                                      to trichlorophenol and/or pentachlorophenol.
as a result of eating meat, milk, eggs, fish and
                                                      Workers exposed only to trichlorophenol had
related products, as TCDD is persistent in the
                                                      mean lipid-adjusted TCDD levels of 15.9 ppt,
environment and accumulates in animal fat.
                                                      compared with 6.5 ppt in unexposed workers and
Occupational exposures to TCDD at higher
                                                      3.3 ppt in community controls. Those exposed
levels have occurred since the 1940s as a result of
                                                      to pentachlorophenol only had mean TCDD
production and use of chlorophenols and chlo-
                                                      concentrations of 8.0 ppt; workers exposed to
rophenoxy herbicides. Even higher exposures
                                                      both chemicals had mean TCDD levels of 13.9
have occurred sporadically in relation to acci-
                                                      ppt; and tradesmen with plant-wide responsi-
dents in these industries (IARC, 1997).
                                                      bilities had mean levels of 20.7 ppt. A follow-
     Mean background levels of TCDD in human
                                                      up study to evaluate the influence of various
tissues are in the range of 2–3 ng/kg (parts per
                                                      factors on TCDD concentrations in serum of 412
trillion; ppt) fat [because PCDDs are stored in
                                                      workers exposed to penta- and trichlorophenol,
fat tissue, body burdens of PCDDs are often
                                                      showed that age and body fat were important
expressed as concentration in lipid, e.g. 100 ppt

                                                                                                         3
IARC MONOGRAPHS – 100F


determinants, whereas diet and jobs-outside-           62.4 ng/kg for the two control groups (Ryan &
the-plant had little impact (Burns et al., 2008).      Schecter, 2000).
    To estimate job-specific exposures over time           Several exposure-response analyses have been
at a facility in New Zealand that manufactured         performed in the industrial cohorts that served
2,4,5-T along with other products between 1962         as a basis for the previous IARC Monographs
and 1988, Aylward et al. (2010) integrated avail-      evaluation (Becher et al., 1998; Flesch-Janys et al.,
able work records, TCDD pharmacokinetic data,          1998; Hooiveld et al., 1998; Steenland et al., 1999,
and serum-sampling data from 346 workers.              2004; Crump et al., 2003).
Estimated TCDD concentrations in serum were
below 300 ppt lipid for all individuals in the         1.3.2 Non-occupational exposure to dioxins
cohort over the entire study period, i.e. lower than
estimates for other 2,4,5-T worker populations.             PCDDs, including TCDD, have been measured
    McLean et al. (2009) measured dioxin concen-       in all environmental compartments including
trations in serum of 94 randomly selected former       ambient air, surface water, groundwater, soil,
sawmill workers (71 exposed to pentachloroph-          and sediment. While the manufacture and use of
enol, 23 non-exposed) in New Zealand, twenty           chlorinated compounds – chlorophenols, chlo-
years after the use of pentachlorophenol (PCP)         rinated phenoxy herbicides – were important
had ceased. The authors compared age-adjusted          sources of PCDD-release into the environment
dioxin levels in the exposed and non-exposed           in the past, the restricted manufacture of many
groups, examined the effect of duration and            of these compounds has substantially reduced
intensity of the exposure to PCP, and compared         their contribution to environmental pollution.
congener profiles with those found in the commer-      It is now recognized that incineration/combus-
cial-grade PCP used at the time. Mean levels in        tion processes are the most important sources
exposed and unexposed workers were 1.88 pg/g           of PCDDs to the environment (Zook & Rappe,
(range, 0.51–4.13) and 1.48 pg/g, respectively.        1994; ATSDR, 1998).
The congener profiles in serum were consistent              The identified sources of environmental
with those in PCP solutions, and dioxin levels         release of TCDDs have been grouped into four
increased with both employment duration and            major categories: incineration sources (munic-
estimated exposure intensity.                          ipal waste, hospital waste, hazardous waste,
    In a study of Russian workers who manu-            sewage sludge), combustion sources (cement
factured phenoxy herbicides and related                kilns, wood-burning, diesel vehicles, coal-fired
compounds in the 1960s, workers who handled            utilities, crematoria), industrial sources (pulp
2,4,5-T (n = 34) had median blood-lipid TCDD           and paper mills, chemical manufacturing, metal
concentrations of 165.7 ng/kg (parts per trillion),    industry), and reservoir sources (biochemical
with a range from 35 to 1680 ng/kg. Workers who        processes, photolytic processes, forest fires, acci-
manufactured 2,4-dichlorophenoxyacetic acid            dental releases) (Kulkarni et al., 2008).
(2,4-D; n = 6) had median levels of 68.9 ng/kg.             Human exposure to all dioxin-like
Children of workers who handled 2,4,5,-T (n = 8)       compounds is usually calculated in terms of
and administrative workers (n  =  5) had higher        toxic equivalence quotients (TEQs).
median levels than two control groups drawn               Because the various polychlorinated dibenzo-
from the general population (n = 60): the median          p-dioxins, polychlorinated dibenzofurans,
                                                          and polychlorinated biphenyls have different
blood-lipid TCDD concentrations in the chil-
                                                          activity levels, a toxic equivalence quotient
dren and administrative staff were 39.5 and               (TEQ) is calculated by standardizing the indi-
31.0 ng/kg, respectively, compared with 12 and            vidual congener levels detected in each sample,

4
2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126


   multiplying them with the appropriate toxic            There is evidence from the NHANES serum
   equivalency factor (TEF), and summing these        PCDD/F data (including TCDD) that concentra-
   normalized values. TEFs have been established
                                                      tions of these compounds in the US population
   by the World Health Organization and are
   calculated relative to 2,3,7,8-TCDD (Van den       are declining. Median serum-lipid concentra-
   Berg et al., 2006; Charnley & Kimbrough, 2006;     tions (population-weighted) of PCDDs/Fs were
   see also Section 4).                               13.46, 13.98 and 11.39 TEQ/g lipid for 1999–2000
     The US Environmental Protection Agency           (n = 1271), 2001–2002 (n = 1244), and 2003–2004
(USEPA) reported that emissions from quan-            (n  =  1290), respectively. When the temporal
tified sources – waste incineration, pesticide        trends are examined by age, median levels appear
manufacture, chlorine bleaching of pulp and           to have declined in the younger part of the popu-
paper – in the USA decreased from about 14 000        lation and remained essentially constant (or have
g TEQ/year in 1987 to approximately 1500 g            slightly increased) in the older part (LaKind
TEQ/year in 2000 (a 90% reduction). This decline      et al., 2009).
is expected to continue (Charnley & Kimbrough,            Several exposure studies have shown that
2006; USEPA, 2006).                                   some US Viet Nam veterans who were exposed to
     People are exposed to PCDDs primarily            Agent Orange had serum TCDD levels up to 600
through foods that are contaminated as a result of    ppt in lipid many years after they had left Viet
the accumulation of these substances in the food-     Nam, compared with values of approximately 1–2
chain and in high-fat foods, such as dairy prod-      ppt of TCDD for the general population (Kahn
ucts, eggs, animal fats, and some fish. Additional    et al., 1988; Schecter et al., 1990, 1992; Michalek
exposure sources include industrial accidents         et al., 1995). In Viet Nam, TCDD levels up to
(Baccarelli et al., 2002) and several miscellaneous   1  000  000 ppt have been found in soil or sedi-
exposures (Yoshimura, 2003; Kulkarni et al.,          ment from Agent Orange-contaminated areas
2008). Because dioxins are fat-soluble, lowering      3–4 decades after spraying. In addition, elevated
the fat content in food can reduce the intake of      concentrations have been measured in food and
dioxin. The average adult in the USA has a daily      wildlife in Viet Nam (Olie et al., 1989) as well as
TEQ intake of approximately 1 pg/kg, lower            in Vietnamese people from contaminated areas
than a decade ago, whereas a nursing infant has       (Schecter et al., 2001, 2002, 2003; Dwernychuk
an average TEQ intake of 35–53 pg/kg bw/day           et al., 2002; Schecter et al., 2006).
(Schecter et al., 1994; USEPA, 2004; Schecter             Bates et al. (2004) determined persistent orga-
et al., 2006).                                        nochlorines, including TCDD, in serum of the
     Data on TCDD concentrations in lipids have       non-occupationally exposed New Zealand popu-
been collected over a 30-year period (1970–2000)      lation in 1996–1997. The weighted mean concen-
among the general population in the USA,              tration of TCDD in adult New Zealanders was
Canada, Germany, and France. Mean lipid-              2.3 ng/kg lipid weight basis (range, < 1–7.0 ng/kg).
levels of TCDD steadily decreased nearly 10-fold      The age group-specific data showed a trend
over this time period, with lipid-adjusted TCDD       towards higher concentrations in the older age
concentratrions of about 2 ppt in the year 2000.      groups.
On the basis of pharmacokinetic modelling,                Several recent studies have assessed and
mean concentrations of TCDD in the general            reviewed the exposure to and intake of dioxins,
population are likely to decrease further to 0.5–1    including TCDD, from dietary sources (Liem
ppt by 2015, even if intake levels do not decrease    et al., 2000; Tsutsumi et al., 2001; Huwe, 2002;
further (Aylward & Hays, 2002; Hays & Aylward,        Parzefall, 2002; Baars et al., 2004; Charnley &
2003).                                                Doull, 2005; Nakatani et al., 2005; Larsen, 2006;

                                                                                                        5
IARC MONOGRAPHS – 100F


Sasamoto et al., 2006; Gies et al., 2007; Todaka       European tissue samples, PeCDF levels are on
et al., 2008).                                         average 13 ppt TEQ (lipid-adjusted) and repre-
                                                       sent approximately 36% of the TEQ contributed
1.3.3 Human exposure to polychlorinated                by PCDDs and PCDFs. PeCDF is the highest
      dibenzofurans, polychlorinated                   contributor of the PCDF class of DLCs to the
      biphenyls and dioxin-like compounds              total TEQ, based on both intake levels and tissue
                                                       concentrations.
     Due to high lipophilicity and low solubility in       The majority (90%) of ambient human expo-
aqueous media, polychlorinated dibenzofurans           sure to dioxin-like compounds occurs through
(PCDFs) accumulate in the fat tissue of animals.       the ingestion of food containing PCB residues.
The highest concentrations of PCDFs are found          Levels of PCB 126 in food range from 0.05 to
in fish, meat, eggs, and dairy products (Schecter      0.83 pg/g. Human exposure to all dioxin-like
et al., 1994; USEPA, 2000b). This results in           compounds is usually calculated in terms of toxic
widespread exposure of the general population          equivalents (TEQs). On a TEQ basis, it is esti-
to PCDFs and related dioxin-like compounds,            mated that humans are exposed via food to 22 pg
with an estimated 90% of human exposure due            TEQ/day (for a 70-kg person) from dioxin-like
to ingestion of contaminated food, and a small         PCBs of which PCB 126 (13 pg/day) accounts for
fraction via inhalation and dermal absorption.         60% of the TEQ intake. Bioaccumulation of PCBs
     Human exposure to all dioxin-like                 results in persistent levels of these substances in
compounds is usually calculated in terms of            human tissues. With an average concentration of
TEQs (see definition above). Adult daily intake        12 pg TEQ/g lipid, PCB 126 accounts for approxi-
of dioxin-like compounds including PCDDs,              mately half of the PCB TEQ in human tissues
PCDFs and dioxin-like PCBs from all sources            (USEPA, 2000b).
is estimated to be approximately 70pg TEQ/day,
where TEQ reflects the potency-adjusted amount
of all dioxin-like compounds. The intake from all      2.	 Cancer in Humans
sources of PCDDs and PCDFs is estimated to be
45pg TEQ/day and intake from dioxin-like PCBs              Human exposures related to occupation or
is 25pg TEQ/day. Approximately 90% of the daily        accidents have led to tissue concentrations of
intake is from food sources (40pg TEQ/day for          2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)
PCDDs and PCDFs and 22pg TEQ/day for dioxin-           that are 10–100-fold higher than average back-
like PCBs). Intake of PeCDF from food is approx-       ground levels in the 1980s. The highest expo-
imately 6.6 pg per day and represents 16% of the       sures occurred in industrial cohorts of workers
total intake of PCDDs and PCDFs on a TEQ basis.        producing phenoxy herbicides and chloroph-
This level of exposure together with the long half-    enols, while exposure to professional sprayers
life of dioxin-like compounds in humans leads to       of these compounds was considerably lower. It
persistent body burdens in humans in the range         has been shown that TCDD levels in professional
of 25 pg TEQ/g lipid (USEPA, 2000b). Depending         applicators increase considerably above back-
upon dietary practice and proximity to specific        ground only after several years of spraying of
sources of exposure, some populations may have         TCDD-contaminated chemicals. For example, in
higher exposure or body burdens. In contrast to        the most heavily exposed applicators of 2,4,5-T
the general population, several specific groups        in New Zealand, who applied this chemical
may have been exposed to much higher levels of         for at least 180 months, the estimated mean
PeCDF as a result of occupational exposure. In

6
2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126


serum concentration of TCDD at the time of                   industrial cohorts, many of them not reported in
blood drawing was 53 ng/kg (Smith et al., 1992).             separate publications, as well as information on
Occasional spraying is unlikely to lead to any               professional applicators. Most of the industrial
measurable increase in TCDD level.                           cohort studies include analyses of subcohorts
    The evaluation of the evidence of carcino-               considered to have the highest exposure and/or
genicity of TCDD was based on studies with                   longest latency. These cohorts and their respec-
direct measurements of TCDD and studies                      tive high-exposure subcohorts are the focus
involving heavy exposure to herbicides likely                of this evaluation. In reporting the findings,
to be contaminated with TCDD. There are                      preference has been given to the most updated
numerous studies that assessed dioxins, furans               follow-up, unless earlier publications presented
and polychlorobiphenyls (PCBs) in workers, but               evidence not included in a later publication, e.g.
these are not systematically reviewed here. These            results by exposure classifications of interest.
studies indicate that the highest exposure occurs            Additional studies of herbicide applicators, both
in industrial settings producing 2,4,5-T. There              cohort and case–control studies, which have
are also numerous studies in workers evaluating              considerably lower exposures to TCDD, are not
a wide range of health effects. Table 2.1 (available         considered critical for the evaluation and are not
at http://monographs.iarc.fr/ENG/Monographs/                 reported in Table  2.2 (available at http://mono-
vol100F/100F-22-Table2.1.pdf) shows estimated                graphs.iarc.fr/ENG/Monographs/vol100F/100F-
exposures to TCDD in industrial workers, in                  22-Table2.2.pdf), Table  2.3 (available at http://
workers handling and spraying 2,4,5-T and in the             mono g r aph s . i a rc . f r/ E NG/ Mono g r a ph s /
population in Seveso, Italy. Average exposures in            vol100F/100F-22-Table2.3.pdf),         Table     2.4
industrial workers are the highest. The effects of           (available at http://monographs.iarc.fr/ENG/
TCDD and those of the products in which it was               Monographs/vol100F/100F-22-Table2.4.pdf ),
found cannot be separated in most of the epide-              or Table  2.5 (available at http://monographs.
miological studies; however, the focus here is on            iarc.fr/ENG/Monographs/vol100F/100F-22-
the contaminant. The most important studies for              Table2.5.pdf). Among the studies not included,
the evaluation of the carcinogenicity of TCDD                there are several that have been widely quoted
are cohort studies of herbicide producers, one               and that have been important in responding to
each in the United States (Fingerhut et al., 1991;           concerns in the community and in raising public
Steenland et al., 1999, 2001), the Netherlands               awareness regarding potential effects of dioxin
(Bueno de Mesquita et al., 1993; Hooiveld et al.,            exposure, such as Ketchum & Aktar (1996),
1998; Boers et al. 2010), two in Germany (Manz               Ketchum et al. (1999), and Hardell & Sandström
et al., 1991; Ott et al., 1993; Flesch-Janys et al., 1995,   (1979).
1998; Becher et al., 1996), and one cohort of resi-
dents in a contaminated area from Seveso, Italy
(Bertazzi et al., 2001; Pesatori et al., 2009). These
                                                             2.1	Description of the most
studies involve the highest exposures to TCDD                    informative studies
among all epidemiological studies, although the              2.1.1	 US NIOSH cohort
exposures at Seveso were lower and the follow-up
was shorter than those in the industrial settings.               The largest study of production workers in
In addition, the multicountry cohort study from              the US exposed to PCDDs was conducted by the
IARC (Saracci et al., 1991; Kogevinas et al., 1995,          National Institute for Occupational Safety and
1997) is of special interest because it includes             Health (NIOSH) and published by Fingerhut et
three of four high-exposure cohorts and other                al. (1991) and Steenland et al. (1999, 2001). This

                                                                                                                 7
IARC MONOGRAPHS – 100F


12-plant cohort study included most workers in            detailed individual job histories. Two nested
the USA likely to have been exposed to TCDD               case–control studies of soft-tissue sarcoma and
in chemical manufacturing, comprising 5000                non-Hodgkin lymphoma were conducted by
men with work records showing assignment to               Kogevinas et al. (1995). The international cohort
a production or maintenance job in a process              studied by Saracci et al. (1991) was updated
involving TCDD contamination. Serum levels                and expanded with the data of Fingerhut et al.
of TCDD in 253 cohort members at two plants               (1991), Becher et al. (1996), and Kogevinas et al.
measured in 1987 averaged 233 ng/g lipid,                 (1997). TCDD was measured in serum samples
compared with 7 ng/g lipid in a group of 79 unex-         for workers in Germany, the Netherlands and the
posed workers. Levels increased to 418 ng/kg for          USA. Results from cohorts in specific countries
119 workers exposed for more than one year.               have been published separately (Coggon et al.,
Estimates of TCDD exposure were based on                  1991; Lynge, 1993).
occupational records, on an exposure matrix
based on industrial hygiene measurements,                 2.1.4	 German cohorts
and on modelling based on measured TCDD in
serum samples. A series of publications on two               Several reports have considered workers
separate plants were available (Zack & Suskind,           from a chemical plant operated by Boehringer-
1980; Zack & Gaffey, 1983; Cook et al., 1986; Ott         Ingelheim, Hamburg, Germany. This plant
et al., 1987; Bond et al., 1989; Collins et al., 1993).   produced herbicides heavily contaminated with
                                                          TCDD and other PCDDs/PCDFs (Manz et al.,
                                                          1991; Flesch-Janys et al., 1995, 1998; Becher et al.,
2.1.2	 German accident cohort
                                                          1996). In the latter study, workers from three
    In the 1953 accident at the 2,4,5-trichlo-            other German plants were also considered.
rophenol (TCP) production unit of BASF at                 TCDD analyses were done on serum samples
Ludwigshafen, Germany, the total number of                from the workers in the Boehringer-Ingelheim
employees identified as being involved directly           cohort.
or in the subsequent clean-up, repair or main-
tenance activities was 247 (243 men, 4 women).            2.1.5	 Dutch cohorts
Analyses of adipose tissue and blood from
groups of these workers were conducted. Part of              The mortality of two cohorts of workers
the cohort was first studied by Thiess et al. (1982)      employed between 1955 and 1986 in the synthesis
and was completed by Ott & Zober (1996).                  and formulation of phenoxy herbicides and chlo-
                                                          rophenols in the Netherlands has been studied
                                                          (Bueno de Mesquita et al., 1993). In one of the
2.1.3	 IARC multicountry study
                                                          plants (A), where the production was focused
    An international cohort of workers exposed            on 2,4,5-T and derivatives, an accident in 1963
to phenoxy herbicides and chlorophenols was set           caused a release of PCDDs, including TCDD.
up by the International Agency for Research on            Serum samples have been analysed for the pres-
Cancer, France (Saracci et al., 1991). The cohort         ence of TCDD. The study has been updated
included 16 863 men and 1527 women employed               (Hooiveld et al., 1998; Boers et al., 2010)
in production or spraying, distributed among 20
cohorts from ten countries. Exposure assessment
was based on plant-production records collected
in each factory through questionnaires and on


8
2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126


2.1.6 Seveso population exposed during an             (NIOSH, Boehringer-Ingelheim, Germany, and
      industrial accident                             BASF, Germany) found a statistically significant
                                                      (P  =  0.02) trend in total cancer mortality with
    On 10 July 1976, a runaway reaction led to        increasing exposure to dioxin (Crump et al.,
a blow-out of a TCP-production reactor at the         2003). The trend tests show an increase in total
ICMESA plant at Seveso, ltaly. The chemical cloud     cancers at cumulative TEQ – a metric TCDD-like
that was released from the reactor contained a        compounds that is defined here as the amount
substantial amount of TCDD. The contaminated          of TCDD that would produce the same toxicity
area was subdivided into Zones A and B, and           as a mixture of TCDD-like compounds – serum
Zone R in descending order of TCDD contami-           levels that would result from lifetime intake of
nation in the soil. The mortality and cancer inci-    7 pg TEQ/kg body weight/day. A linear dose–
dence in the population of Seveso exposed during      response provided a good fit to the combined
this industrial accident were investigated. The       data. There was no overall increase of cancer in the
exposed and referent populations were followed-       population in Seveso, with only minor increases
up as if they belonged to a unique cohort, blind      observed for all-cancer mortality and incidence
to the exposure status of the subjects. The follow-   at 15 or more years since the accident in the most
up after 20 years was > 99% successful (Bertazzi      heavily exposed zones. [The overall increase iden-
et al., 2001; Pesatori et al., 2009)                  tified in all industrial cohorts, and the positive
                                                      trends with increased exposure that are based on
2.2	All cancers                                       internal comparisons, reinforce an overall posi-
                                                      tive association between all cancers combined
    An increased risk for all cancers combined        and exposure to TCDD, making it less likely that
was found in the industrial cohort studies cited      the increase is explained by confounding, either
above in the USA, Germany, and the Netherlands        by smoking or by other exposures to carcinogens
and to a lesser extent in the international cohort    in the industrial setting.]
(see Table  2.2, online). The magnitude of the
increase is generally small. It is higher in subco-
horts considered to have the heaviest TCDD            2.3	Cancer of the lung
exposure, e.g. the chloracne subcohort in the              An increased risk for lung cancer was observed
NIOSH study. Furthermore, statistically signifi-      in the industrial cohort studies, especially in the
cant positive dose–response trends for all cancers    more highly exposed subcohorts (see Table 2.3,
combined were present in the NIOSH cohort and         online). The relative risk for lung cancer in the
in the largest and most heavily exposed German        highly exposed subcohorts was around 1.5 in
cohort. A positive trend (P = 0.05) was also seen     several studies. [It is possible that relative risks
in the smaller German cohort where an accident        of this order for lung cancer could result from
occurred with release of large amounts of TCDD.       confounding by smoking, but this would only
However, the positive trend in this cohort was        be the case if there were a pronounced differ-
limited to smokers. Cumulative dose in these          ence in smoking habits between the exposed and
trend analyses was estimated by combining             the referent populations, a difference that seems
data from TCDD concentrations in blood and            unlikely. Therefore, confounding by smoking
information on job categories, work processes         can probably not explain all the excess risk for
and calendar time of exposure. A metanal-             lung cancer, although it could explain part of it.
ysis of data from three cohorts occupation-           It is also possible that other occupational carcin-
ally exposed to TCDD and related compounds            ogens, many of which would affect the lung, are

                                                                                                        9
IARC MONOGRAPHS – 100F


causing some confounding.] In Seveso, increased       were mostly non-significant and below 2 (see
mortality and cancer incidence for lung cancer        Table  2.5, online). A case–control study nested
was observed at more than 15 years since the          in the IARC cohort provided weak evidence of
accident.                                             a dose–response relationship with estimated
                                                      exposure to TCDD. [Although it is plausible that
                                                      other chemicals cause non-Hodgkin lymphoma,
2.4	Soft-tissue sarcoma                               strong potential confounding factors are not
    An association between soft-tissue sarcoma        known. The lack of complete consistency among
and spraying of phenoxy herbicides was first          the cohorts and the weak effect detected in most
suggested by results from case–control studies        of the positive studies, however, caution against
in Umea, Sweden (Hardell & Sandström, 1979).          a causal interpretation of the findings.]
Exposure to TCDD in these and other commu-
nity-based case–control studies is, however, not      2.6	Other cancers
accurately estimated. An excess risk for soft-
tissue sarcoma, based on a small number of                Increased risks for several other malignant
deaths, has been reported in the largest industrial   neoplasms have been sporadically reported
cohorts, specifically those of NIOSH and IARC         among workers exposed to TCDD, and at
(see Table  2.4, online). In both, the mortality      Seveso. Most notable are risks for breast and
ratios (SMRs) tended to be higher among the           rectal cancers and myeloid leukaemia in Seveso,
most exposed subcohorts. Incidence data for           bladder cancer in the NIOSH and Dutch cohorts,
soft-tissue sarcoma were generally not available.     multiple myeloma in the NIOSH cohort, cancers
A dose–response relationship, with estimated          of the oral cavity and pharynx in the German
exposure to TCDD, was found in a case–control         cohorts, genital cancers in the Dutch cohort, and
study nested in the IARC cohort; however, strong      kidney cancer in the IARC cohort. [The avail-
positive trends were also found with exposure         able results are not fully consistent, and several
estimates for 2,4-dichlorophenoxyacetic acid          studies have not reported the results for each
(2,4-D) and 2,4,5-trichlorophenoxyacetic acid         individual cancer site.]
(2,4,5-T). In Seveso, there were no cases of soft-
tissue sarcoma in the most heavily contaminated
Zones A and B. [Soft-tissue sarcomas are subject
                                                      2.7	Synthesis
to serious misclassification on death certificates.        Overall, the strongest evidence for the carci-
Although it is unlikely that this occurs differ-      nogenicity of TCDD is for all cancers combined,
entially in the exposed and the referent popula-      rather than for any specific site. The relative risk for
tions, re-classification of a few cases would have    all cancers combined in the most highly exposed
important consequences on results based on            and longer-latency subcohorts is around 1.4. In
small numbers.]                                       dose–response analyses, higher relative risks are
                                                      observed for the groups with the highest meas-
2.5	Non-Hodgkin lymphoma                              ured and modelled exposure to TCDD. While
                                                      this relative risk for all neoplasms does not appear
    An increased risk for non-Hodgkin lymphoma        likely to be explained by confounding, particu-
was found in most of the populations studied          larly since dose–response was typically based
in the four industrial cohort studies and in the      on internal comparisons among workers of the
Seveso population, although the relative risks        same cohort, this possibility cannot be excluded.


10
2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126


The evidence for specific cancers is strongest         subcutaneous injection in one study in hamsters.
for lung cancer, soft-tissue sarcoma and non-          TCDD produced tumours in both sexes of mice
Hodgkin lymphoma, but confounding cannot be            and rats, and in multiple organs and tissues.
ruled out for lung cancer, while the findings on           Oral administration of TCDD caused
soft-tissue sarcoma are based on small numbers.        increased incidences of thyroid follicular
Several studies identified statistically significant   adenomas and hepatocellular adenomas and
increases in many cancers, but findings for other      carcinomas in male and female mice, of alveolar/
cancers including major cancers are, overall,          bronchiolar adenomas and carcinomas in male
inconsistent between studies. It should be borne       mice, and of histiocytic lymphomas and subcu-
in mind that the general population is exposed         taneous fibrosarcomas in female mice. In rats,
to levels that are much lower than those experi-       it caused increased incidences of hepatocellular
enced by the industrial populations.                   adenomas in males and females, cholangiocarci-
    The Working Group did not review the epide-        nomas and hepatocellular carcinomas in females,
miological evidence of other PCDDs, PCDFs or           lung cystic keratinizing epitheliomas and
PCBs with a dioxin-like activity.                      squamous-cell carcinomas in females, adrenal
                                                       gland (cortex) adenomas and squamous-cell
                                                       carcinomas of the hard palate/nasal turbinates
3.	 Cancer in Experimental Animals                     in males and females, tongue squamous-cell
                                                       carcinomas and thyroid follicular adenomas and
3.1	2,3,7,8-Tetrachlorodibenzo-para-                   carcinomas combined in males, subcutaneous
                                                       fibromas in males and subcutaneous fibrosa-
    dioxin                                             rcomas in females, and pituitary adenomas,
    Carcinogenicity studies with several strains       uterine and oral mucosa (gingival) squamous-cell
of rats, mice and Syrian hamsters treated with         carcinomas and pancreatic adenomas and carci-
2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)          nomas combined in females (Van Miller et al.,
via the oral route (gavage or diet), by intra-peri-    1977; Kociba et al., 1978; Tóth et al., 1979, NTP,
toneal injection, or by skin application have been     1982a, 2006a; Della Porta et al., 1987; Goodman
reviewed in IARC Monograph Volume 69 (IARC,            & Sauer, 1992; Hays et al., 1997, Yoshizawa et al.,
1997). At the time, the review of the available        2005). Skin application or gavage caused benign
data led to the conclusion that there is sufficient    and malignant tumours of the skin in female mice
evidence in experimental animals for the carci-        including transgenic mice (NTP, 1982b; Wyde
nogenicity of TCDD. The present Monograph              et al., 2004). Hamsters that received TCDD by
also evaluates relevant carcinogenicity studies in     intraperitoneal or subcutaneous injection devel-
TCDD-treated experimental animals that were            oped squamous-cell carcinomas of the facial
published since 1997. The results of adequately        skin (Rao et al., 1988). Intraperitoneal injection
conducted carcinogenicity studies are summa-           caused increased incidence of hepatocellular
rized below and in Table 3.1 and Table 3.2.            adenomas and carcinomas in female mice and
    TCDD was tested for carcinogenicity by oral        of lymphomas in male and female mice (Della
administration (gavage or dose feed) in four           Porta et al., 1987).
studies in mice and six studies in rats, by skin           Several studies in mice showed that admin-
(topical) application in two studies in mice, by       istration of TCDD with known carcinogens
intraperitoneal injection in one study in mice, one    enhanced the incidence of skin papillomas, lung
study in rats and one study in hamsters and by         adenomas, liver adenomas and hepatoblastomas.
                                                       In female rats, TCDD co-administered with

                                                                                                       11
12
     Table 3.1 Carcinogenicity studies in mice exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)

     Species, strain (sex)   Dosing regimen,                       Results                               Significance            Comments
     Duration                Animals/group at start                Incidence and/or multiplicity of
     Reference                                                     tumours (%)
     Mouse, Swiss-Webster    Skin application                      Data given for vehicle                                        Purity 99.4%
     (M, F)                  TCDD applied to the skin of male      controls, TCDD (alone)- and                                   In the DMBA-TCDD experiment, the
     99 or 104 wk            (0.001 µg/animal) or females          TCDD+DMBA-treated groups.                                     lack of groups treated with DMBA alone,
     NTP (1982b)             (0.005 µg/animal) per application     Skin:                                                         precluded interpretation of the results.
                             (equivalent to 0.15 µg/kg/wk and
                                                                   Fibrosarcomas–
                             0.75 µg/kg/wk respectively), 3 × /
                                                                                                                                                                             IARC MONOGRAPHS – 100F




                             wk on alternate days in 0.1 ml        3/42 (7%), 6/28 (21%), 5/30 (17%)     NS (M)
                             acetone. Vehicle controls were        (M);
                             given 0.1 ml acetone 3 × /wk.         2/41 (5%), 8/27 (30%), 8/29 (27%)     TCDD: P = 0.007
                             Groups of mice of either sex were     (F)                                   vs vehicle control
                             also given a single application                                             (F)
                             of 50 µg DMBA one week before                                               TCDD+DMBA:
                             TCDD applications. This study                                               P = 0.01 vs vehicle
                             did not include a control group                                             control (F)
                             treated with DMBA alone
                                                                   Myxomas–
                             Untreated controls: 15 mice/
                             group                                 0/41, 0/27, 1/29 (3%) (F)             NS
                             Vehicle-control: 45 animals/sex
                             TCDD: 30 animals/sex
                             TCDD + DMBA: 30 animals/sex

     Mouse, Tg.AC (F)        Skin application                      Skin (squamous cell papillomas):                              Purity 99%
     26 wk                   0, 5, 17, 36, 76, 121, 166, 355, or   0/20, 1/20 (5%), 3/20 (15%), 11/20    P < 0.01 (15, 33, 52,   Survival for TCDD-treated mice was
     Wyde et al. (2004)      760 ng/kg bw TCDD in acetone          (55%), 10/20 (50%), 13/20 (65%),      71, 152, and 326        similar as in the controls, except for
                             applied topically 3 × /wk for 26      17/20 (85%), 19/20 (95%), 20/20       ng/kg/d)                lower survival rates observed in mice
                             wk (equivalent to 0, 2.1, 7.3, 15,    (100%)                                                        receiving 33 and 52 ng TCDD/kg (65
                             33, 52, 71, 152, 326 ng/kg/d)                                                                       and 50%, respectively) vs controls (85%);
                             20 animals/group                      Skin (squamous cell carcinomas):                              however, this was thought not to be
                                                                   0/20, 0/20, 1/20 (5%), 1/20 (5%),   P < 0.01 (52, 71,         treatment-related because the survival
                                                                   3/20 (15%), 5/20 (25%), 8/20 (40%), 152, 326 ng/kg/d)         rate of higher dose groups was similar to
                                                                   14/20 (70%), 16/20 (80%)                                      that of the control group.
                                                                   Keratoacanthomas:                                             The response of TCDD-induced
                                                                                                                                 papilloma formation in the skin was
                                                                   0/20, 0/20, 0/20, 0/20, 3/20 (15%),   NS
                                                                                                                                 greater in mice exposed to TCDD
                                                                   3/20 (15%), 2/20 (10%), 3/20 (15%),
                                                                                                                                 by the dermal route than by oral
                                                                   1/20 (5%)
                                                                                                                                 administration (see gavage study by
                                                                                                                                 Wyde et al. (2004), below)
Table 3.1 (continued)
     Species, strain (sex)     Dosing regimen,                    Results                               Significance           Comments
     Duration                  Animals/group at start             Incidence and/or multiplicity of
     Reference                                                    tumours (%)
     Mouse, Swiss/H/Riop (M) Gavage                               Liver (tumours):                                             Purity NR
     Lifetime                0, 0.007, 0.7, 7.0 µg/kg bw in       7/38 (18%), 13/44 (29%), 21/44        P < 0.01 (0.7 µg/      Tumour type NR
     Tóth et al. (1979)      sunflower oil, once/wk for 1 yr.     (48%), 13/43 (30%)                    kg)                    Average lifespan decreased considerably
                             Controls received sunflower oil                                                                   in the 7.0-µg/kg dose group (428
                             45 animals/group                                                                                  d) compared with controls (588 d).
                                                                                                                               [Mortality-adjusted analysis was not
                                                                                                                               performed and, therefore, the tumour
                                                                                                                               incidence in the high-dose group may
                                                                                                                               have been underestimated.]
     Mouse, B6C3F1 (M, F)      Gavage                             Liver (hepatocellular adenomas):                             Purity 99.4%
     104 wk                    0.01, 0.05, 0.5 µg/kg bw 2x/wk                                                                  Toxic hepatitis:
     NTP (1982a)               (M) or 0.04, 0.2, 2.0 µg/kg bw                                                                  1/73, 5/49, 3/49, 44/50 (M);
                                                                  7/73 (9%), 3/49 (6%), 5/49 (10%),     P = 0.024 (trend,
                               2x/wk (F) as a suspension in 9:1                                                                0/73, 1/50, 2/48, 34/47 (F)
                                                                  10/50 (20%) (M);                      M)
                               corn-oil/acetone at a volume of
                               0.05 ml/100 g bw, for 104 wk       2/73 (3%), 4/50 (8%), 4/48 (8%),
                               Vehicle controls: 75 mice/sex      5/47 (11%) (F)
                               Untreated controls: 25 mice/sex
                                                                  Liver (hepatocellular carcinomas):
                               TCDD: 50 mice/sex

                                                                  8/73 (11%), 9/49 (18%), 8/49 (16%),   P = 0.002 (M)
                                                                  17/50 (34%) (M);                      P = 0.002 (trend,
                                                                                                        M)
                                                                  1/73 (1%), 2/50 (4%), 2/48 (4%),      P = 0.014 (F)
                                                                  6/47 (13%) (F)                        P = 0.008 (trend,
                                                                                                        F)
                                                                  Liver (hepatocellular adenomas or
                                                                  carcinomas):
                                                                  15/73 (20%), 12/49 (24%), 13/49       P < 0.001 (high-
                                                                  (26%), 27/50 (54%) (M);               dose M)
                                                                                                        P < 0.001 (trend,
                                                                                                        M)
                                                                  3/73, (4%), 6/50 (12%), 3/48 (6%),    P < 0.005 (high-
                                                                  11/47 (23%) (F)                       dose F)
                                                                                                        P < 0.002 (trend, F)
                                                                                                                                                                         2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126




13
14
     Table 3.1 (continued)
     Species, strain (sex)   Dosing regimen,          Results                              Significance           Comments
     Duration                Animals/group at start   Incidence and/or multiplicity of
     Reference                                        tumours (%)
     Mouse, B6C3F1 (M, F)                             Thyroid (follicular adenomas):
     104 wk
     NTP (1982a)
                                                      0/69, 3/48 (6%), 0/48, 0/49 (M);     P = 0.008 (trend
     Contd.
                                                                                           M)
                                                      0/69, 3/50 (6%), 1/47 (2%), 5/46     P = 0.009 (high-
                                                      (11%) (F)                            dose, F)
                                                                                                                             IARC MONOGRAPHS – 100F




                                                                                           P = 0.016 (trend, F)
                                                      Lung (alveolar/bronchiolar
                                                      adenomas):
                                                      7/71 (10%), 2/48 (4%), 4/48 (8%),    P = 0.006 (trend,
                                                      11/50 (22%) (M)                      M)
                                                      Lung (alveolar/bronchiolar
                                                      adenomas or carcinomas):
                                                      10/71 (14%), 2/48 (4%), 4/48 (8%),   P = 0.004 (trend,
                                                      13/50 (26%) (M)                      M)
                                                      Subcutaneous tissue
                                                      (fibrosarcomas):
                                                      1/74 (1%), 1/50 (2%), 1/48 (2%),     P = 0.032 (high-
                                                      5/47 (11%) (F)                       dose, F)
                                                                                           P = 0.007 (trend,
                                                                                           F)
                                                      Lymphoid tissue (histiocytic
                                                      lymphomas):
                                                      9/74 (12%), 4/50 (8%), 8/48 (17%),   P = 0.016 (high-
                                                      14/47 (30%) (F)                      dose, F)
                                                                                           P = 0.003 (trend,
                                                                                           F)
Table 3.1 (continued)
     Species, strain (sex)       Dosing regimen,                       Results                              Significance         Comments
     Duration                    Animals/group at start                Incidence and/or multiplicity of
     Reference                                                         tumours (%)
     Mouse, C57BL/6J x C3Hf,     Gavage                                Hepatocellular adenomas:                                  Laboratory grade; purity NR
     (M, F)                      0, 2.5, 5.0 µg/kg bw in 0.01 ml/                                                                Treatment with both doses caused a
     110 wk                      kg bw corn-oil containing 1.2%                                                                  marked depression in mean body weight
     Della Porta et al. (1987)   acetone, once/wk for 52 wk,                                                                     (no significance given) and reduced
                                 followed until 104 wk. Controls                                                                 survival (P < 0.001) in male and female
                                 given corn-oil/acetone (~99:1)        10/43, 11/51, 10/50 (M);             P < 0.001, for       mice.
                                 once/wk for 52 wk.                    2/49, 4/42, 11/48 (F)                fatal tumour test    Male mice, treated once by mistake
                                 At 31–39 wk, 41 M and 32 F in                                              (M); P < 0.01, for   with a dose of 25 µg/kg TCDD had an
                                 the 2.5-µg/kg bw group were                                                fatal tumour test    increased mortality shortly after the 2.5-
                                 erroneously treated once with                                              (F); P < 0.001 for   µg/kg treatment. The incidence of other
                                 a dose of 25 µg/kg TCDD. The                                               incidental tumour    tumour types were uniformly low in
                                 treatment of these mice was                                                test (F)             treated and control groups of both sexes,
                                 interrupted for five wk and then      Hepatocellular carcinomas:                                and were not treatment related.
                                 continued until wk 57, as for the
                                 other treated mice. At the end of
                                 treatment, all groups were kept
                                 under observation until 110 wk.
                                 45–55 animals/group                   5/43 (12%), 15/51 (29%), 33/50       P < 0.005, for
                                                                       (66%) (M);                           both fatal and
                                                                       1/49 (2%), 12/42 (29%), 9/48 (19%)   incidental tumour
                                                                       (F)                                  test (M, F)

     Mouse, Tg.AC (F)            Gavage                                Skin (squamous cell papillomas):                          Purity 99%
     26 wk                       0, 105, 450, or 1 250 ng TCDD/kg
                                                                       1/20 (5%), 2/20 (10%), 3/20 (15%),   P < 0.01 (high-
     Wyde et al. (2004)          bw, 5 d/wk, for 26 wk (equivalent
                                                                       11/20 (55%)                          dose)
                                 to 0, 75, 321, 893 ng/kg/d, 5 d/wk)
                                 20 animals/group                      Skin (squamous cell carcinomas):
                                                                       0/20, 0/20, 1/20 (5%), 13/20 (65%)   P < 0.01 (high-
                                                                                                            dose)
                                                                       Keratoacanthomas:
                                                                       0/20, 0/20, 0/20, 1/20 (5%)          NS
                                                                                                                                                                              2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126




15
16
     Table 3.1 (continued)
     Species, strain (sex)       Dosing regimen,                     Results                                Significance           Comments
     Duration                    Animals/group at start              Incidence and/or multiplicity of
     Reference                                                       tumours (%)
     Mouse, immature B6C3        Intraperitoneal injection           B6C3 mice:                                                    Treatment with 30 and 60 µg/kg bw
     and B6C (M, F)              0, 1, 30, 60 µg/kg bw in 0.01 ml/                                                                 TCDD increased mortality in both
     78 wk                       kg bw corn-oil vehicle containing   Hepatocellular adenomas–                                      hybrids (no statistical analysis).
     Della Porta et al. (1987)   1.2% acetone starting at 10 days                                                                  Animals that died within 13 wk of age
                                 of age, once/wk for 5 wk and        6/45 (13%), 5/55 (9%), 5/52 (10%),     P < 0.043 (trend,      were excluded from histopathological
                                 observed until 78 wk of age.        11/43 (26%) (M);                       M)                     evaluation and the statistical analyses.
                                 Controls given corn-oil/acetone     0/42, 1/57 (2%), 1/48 (2%), 5/56       P < 0.014 (trend, F)   The 15 thymic lymphomas were found
                                                                                                                                                                              IARC MONOGRAPHS – 100F




                                 (~99:1)                             (9%) (F)                                                      in animals dying between 16 and 41 wk
                                 B6C3: 151–186; 97 controls          Hepatocellular carcinomas–                                    of age and most of them (11 out of 15)
                                 B6C: 89–138; 105 controls                                                                         were observed within 26 wk of age. Non-
                                                                     3/45 (7%), 1/55 (2%), 9/52 (17%),      P < 0.001 (60 µg/      thymic lymphomas involved mesenteric
                                                                     14/43 (32%) (M);                       kg, M)                 lymph nodes, Peycr patches, and the
                                                                                                            P = 0.002 (trend,      spleen, with secondary involvement of
                                                                                                            M)                     multiple organs.
                                                                     0/42, 0/57, 1/48 (2%), 1/57 (2%) (F)

                                                                     Thymic lymphomas–

                                                                     0/45, 0/55, 1/52 (2%), 2/43 (5%)
                                                                     (M);
                                                                     0/42, 0/57, 0/48, 5/57 (9%) (F)        P < 0.05 (60 µg/
                                                                                                            kg, F)
                                                                     Non thymic lymphomas–

                                                                     1/45 (2%), 2/55 (4%), 1/52 (2%),
                                                                     1/43 (2%) (M);
                                                                     0/42, 1/57 (2%), 8/48 (17%), 3/57      P < 0.05 (30 µg/
                                                                     (5%) (F)                               kg, F)
Table 3.1 (continued)
     Species, strain (sex)           Dosing regimen,                          Results                                  Significance            Comments
     Duration                        Animals/group at start                   Incidence and/or multiplicity of
     Reference                                                                tumours (%)
     Mouse, immature B6C3                                                     B6C mice:
     and B6C (M, F)
     78 wk                                                                    Hepatocellular adenomas–
     Della Porta et al. (1987)
     Contd.                                                                   1/32 (3%), 2/54 (4%), 1/27 (4%),         NS
                                                                              0/30 (M)
                                                                              Thymic lymphomas–

                                                                              0/32, 0/54, 2/27 (7%), 2/30 (7%)         P < 0.05 (trend,
                                                                              (M);                                     M, F)
                                                                              0/48, 0/57, 1/39 (3%), 2/38 (5%) (F)
                                                                              Non thymic lymphomas–

                                                                              0/32, 0/54, 1/27 (4%), 2/30 (7%)         P < 0.05 (trend,
                                                                              (M);                                     M, F)
                                                                              1/48 (2%), 3/57 (5%), 5/39 (13%),
                                                                              3/38 (8%) (F)
     bw, body weight; d, day or days; DMBA, 7,12-dimethylbenz[a]anthracene; F, female; M, male; NR, not reported; NS, not significant; vs, versus; wk, week or weeks; yr, year or years
                                                                                                                                                                                          2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126




17
18
     Table 3.2 Carcinogenicity studies in rats and hamsters exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)

     Species, strain (sex)   Dosing regimen,                 Results                                       Significance                  Comments
     Duration                Animals/group at start          Incidence and/or multiplicity of
     Reference                                               tumours (%)
     Rat, Osborne-Mendel     Gavage                          Liver neoplastic nodules (adenomas):                                        Purity 99.4%
     (M, F)                  0, 0.01, 0.05, 0.5 µg/kg bw     0/74, 0/50, 0/50, 3/50 (M);                   P < 0.005 (trend, M)          Increased incidence of
     104 wk                  twice/wk as a suspension        5/75 (7%), 1/49 (2%), 3/50 (6%), 12/49        P = 0.006 (high-dose F)       hepatotoxicity occurred in the
     NTP (1982a)             in 9:1 corn-oil/acetone at a    (24%) (F)                                     P < 0.001 (trend, F)          high-dose male (0/50, 0/74,
                             volume of 0.05 ml/100 g bw,                                                                                 1/50, 0/50, 14/50 and female
                                                             Liver neoplastic nodules and
                             for 104 wk                                                                                                  (0/49, 0/75, 0/49, 1/50, 32/49)
                                                             hepatocellular carcinomas:
                                                                                                                                                                           IARC MONOGRAPHS – 100F




                             Vehicle controls received 9:1                                                                               rats. One high dose-treated
                             corn-oil/acetone                0/74, 0/50, 0/50, 3/50 (2%) (M);              P < 0.005 (trend, M)          male developed a hepatocellular
                             Vehicle controls: 75 rats/sex   5/75 (7%), 1/49 (2%), 3/50 (6%), 14/49        P = 0.001 (high-dose F)       carcinoma.
                             Untreated controls: 25 rats/    (29%) (F)                                     P < 0.001 (trend, F)
                             sex                             Thyroid:
                             TCDD: 50 rats/sex               Follicular adenomas:
                                                             1/69 (1%), 5/48 (10%), 6/50 (12%), 10/50      P = 0.042 (low-dose), 0.021
                                                             (20%) (M);                                    (mid-dose), 0.001 (high-
                                                             3/73 (4%), 2/45 (4%), 1/49 (2%), 6/47 (13%)   dose M)
                                                             (F)                                           P < 0.006 (trend, M)
                                                             Follicular adenomas/carcinomas:
                                                             1/69 (1%), 5/48 (10%), 8/50 (16%), 11/50      P = 0.042 (low-dose, M),
                                                             (22%) (M);                                    P = 0.004 (mid-dose, M),
                                                             5/73 (7%), 2/45 (4%), 1/49 (2%), 6/47 (13%)   P < 0.001 (high-dose M)
                                                             (F)                                           P < 0.005 (trend, M)
                                                             Adrenal:
                                                             Cortical adenomas–
                                                             6/72 (8%), 9/50 (18%), 12/49 (24%), 9/49      P = 0.015 (mid-dose M)
                                                             (18%) (M);
                                                             11/73 (15%), 8/49 (16%), 4/49 (8%), 14/46     P = 0.019 (trend, F)
                                                             (30%) (F)
                                                             Subcutaneous tissue:
                                                             Fibromas–
                                                             3/75 (4%), 1/50 (2%), 3/50 (6%), 7/50 (14%)   P = 0.048 (high-dose M)
                                                             (M)                                           P < 0.01 (trend, M)
                                                             Fibrosarcomas–
                                                             0/75, 2/50 (4%), 3/50 (6%), 4/49 (8%) (F)     P = 0.023 (high-dose F)
                                                             Pituitary (adenomas):
                                                             1/66 (1%), 5/47 (8%), 2/44 (4%), 3/43 (7%)    P = 0.044 (low-dose F)
                                                             (F)
Table 3.2 (continued)
     Species, strain (sex)     Dosing regimen,                  Results                                         Significance            Comments
     Duration                  Animals/group at start           Incidence and/or multiplicity of
     Reference                                                  tumours (%)
     Rat, Harlan Sprague-      Gavage                           Liver:                                                                  Purity 98%
     Dawley (F)                0, 3, 10, 22, 46, or 100 ng/kg                                                                           Survival of dosed groups was
     105 wk                    bw, 5 d/wk, for up to 105 wk                                                                             similar to that of the vehicle-
     NTP (2006a),              Controls given corn-oil with                                                                             control group. Mean body
     Yoshizawa et al. (2005)   acetone (91:1)                                                                                           weights of the 22-, 46-, 100-ng/
                               A stop-exposure group of 50                                                                              kg core study and stop-exposure
                               females received 100 ng/kg       Hepatocellular adenomas–                                                groups were less than those of
                               TCDD in corn-oil/acetone         0/53, 0/54, 0/53, 0/53, 1/53 (2%), 13/53        P < 0.001 (100 ng/kg)   the vehicle-control group
                               (91:1) for 30 wk and then the    (25%), 2/50 (4%)                                P < 0.001 (trend)
                               vehicle for the remainder of
                                                                Cholangiocarcinomas–
                               the study
                               8–10 animals/group were          0/53, 0/54, 0/53, 1/53, (2%) 4/53 (8%),         P < 0.057 (46 ng/kg).
                               evaluated at 14, 31 or 53 wk;    25/53 (47%), 2/50 (4%)                          P < 0.001 (100 ng/kg)
                               81–82 animals/group                                                              P < 0.001 (trend)
                                                                Lung (cystic keratinizing epitheliomas):
                                                                0/53, 0/54, 0/53, 0/52, 0/53, 9/52 (17%),       P = 0.002 (100 ng/kg)
                                                                0/50                                            P < 0.001 (trend)
                                                                Oral mucosa (gingiva) (squamous cell
                                                                carcinomas):
                                                                1/53 (2%), 2/54 (4%), 1/53 (2%), 0/53, 4/53     P = 0.007 (100 ng/kg)
                                                                (8%), 10/53 (19%), 5/50 (10%)                   P < 0.001 (trend)
                                                                Uterus (squamous cell carcinomas):
                                                                0/53, 0/54, 0/53, 0/53, 5/53 (9%), 0/53, 2/50   P = 0.032 (46 ng/kg)
                                                                (4%)
                                                                Pancreas (acinar adenomas or
                                                                carcinomas):
                                                                0/51, 0/54, 0/52, 0/53, 0/52, 3/51 (6%)         P < 0.001 (trend)
                                                                                                                                                                           2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126




19
20
     Table 3.2 (continued)
     Species, strain (sex)   Dosing regimen,                  Results                                     Significance       Comments
     Duration                Animals/group at start           Incidence and/or multiplicity of
     Reference                                                tumours (%)
     Rats, Sprague-Dawley    Diet                             Total tumours:                                                 All animals given 50, 500
     (M)                     Rats were placed on diet         Diet (ppt)                                                     and 1 000 ppb died between
     95 wk                   containing 0, 1, 5, 50, 500                                                  a                  the second and fourth wk on
                                                              0/10, 0/10, 5/10 (50%)a, 3/10 (30%), 4/10       [P = 0.0325]
     Van Miller et al.       ppt or 1, 5, 50, 500, or 1 000   (40%)                                                          study. At the end of the study,
     (1977)                  ppb suspended in acetone                                                                        4/10, 8/10, 6/10, 6/10 and 5/10
                                                              Diet (ppb)
                             and dissolved in corn                                                                           rats were alive in the 0, 1, 5,
                                                              1 ppb–4/10 (40%)
                             oil, for 78 wk after which                                                                      50 and 500 ppt treated rats,
                                                                                                                                                                   IARC MONOGRAPHS – 100F




                                                                                                          b
                             feeding with basal diet was      5 ppb–7/10 (70%)b                               [P = 0.0031]   respectively. No animals were
                             continued. A control group                                                                      alive in the 1- and 5-ppb groups.
                             was maintained on the basal                                                                     Food intake in these groups was
                             diet. At 65 wk, laparotomies                                                                    significantly less than that of the
                             were performed on all            Neoplasms included                                             controls and the animals had
                             animals and biopsies taken       5 ppt: 1 ear duct carcinoma, 1                                 acute toxicity. Weight gain was
                             from all tumours observed.       lymphocytic leukaemia, 1 renal                                 significantly different from that
                             Surviving rats were              adenocarcinoma, 1 malignant                                    of the controls only in the 5-ppb
                             sacrificed at 95 wk.             histiocytoma (peritoneal), 1                                   group. Neoplasms of the liver
                             10 animals/group                 angiosarcoma (skin), 1 Leydig-cell                             occurred only in animals fed 1
                                                              adenoma (testes)                                               or 5 ppb TCDD.
                                                              50 ppt: 1 fibrosarcoma (muscle),
                                                              1 squamous cell tumour (skin), 1
                                                              astrocytoma (brain)

                                                              500 ppt: 1 fibroma (striated muscle), 1
                                                              carcinoma (skin), 1 adenocarcinoma
                                                              (kidney), 1 sclerosing seminoma (testes)

                                                              1 ppb–1 cholangiocarcinoma, 1
                                                              angiosarcoma (skin), 1 glioblastoma
                                                              (brain), 2 malignant histiocytomas
                                                              (peritoneal)
                                                              5 ppb–4 squamous cell tumours
                                                              (lung), 4 neoplastic nodules (liver), 2
                                                              cholangiocarcinomas
Table 3.2 (continued)
     Species, strain (sex)   Dosing regimen,                 Results                                       Significance                 Comments
     Duration                Animals/group at start          Incidence and/or multiplicity of
     Reference                                               tumours (%)
     Rat, Sprague-Dawley     Diet feed                       Liver:                                                                     Purity > 99%
     (Spartan substrain)     0, 0.001, 0.01, 0.1 µg/kg                                                                                  Reduced survivaI was observed
                                                             Hyperplastic nodules–
     (M, F)                  bw/d (equivalent to 0, 22,                                                                                 in high-dose females and in
     24 mo                   210, 2 200, ppt) in the diet.   6/85 (7%), 0/50, 3/50 (6%), 2/50 (4%) (M);                                 mid- and high-dose males.
     Kociba et al. (1978),   Control groups received a                                                                                  Mean body weights of high-dose
     Hays et al. (1997),     basal diet containing the       8/86 (9%), 3/50 (6%), 18/50 (36%), 23/49      P < 0.05; 0.01 and 0.1µg/    males and mid- and high-dose
     Goodman & Sauer         vehicle acetone alone.          (47%) (F)                                     kg (F)                       femaIes were less than those
     (1992)                  Controls: 86 animals/group/     Hepatocellular carcinomas–                                                 of the controls throughout
                             sex                             2/85, 0/50, 0/50, 1/50 (2%) (M);                                           the major portion of the
                             Treated: 50 animals/group/                                                                                 study. Decreased incidence of
                             sex                             1/86 (1%), 0/50, 2/50 (4%), 11/49 (22%) (F)   P < 0.05; 0.1 µg/kg (F)      tumours of the pituitary, uterus,
                                                                                                                                        mammary glands, pancreas,
                                                             Hard palate/nasal turbinates (squamous
                                                                                                                                        adrenal gland occurred in
                                                             cell carcinomas):
                                                                                                                                        treated rats.
                                                             0/85, 0/50, 0/50, 4/50 (8%) (M);              P < 0.05; 0.1 µg/kg (M, F)
                                                             0/86, 0/50, 1/50 (2%), 4/49 (8%) (F)
                                                             Tongue (squamous cell carcinomas):
                                                             0/85, 1/50 (2%), 1/50 (2%), 3/50 (6%) (M);    P < 0.05; 0.1 and 0.01µg/
                                                                                                           kg (M)
                                                             1/86 (1%), 0/50, 0/50, 2/49 (4%) (F)
                                                             Lung (keratinizing squamous cell
                                                             carcinomas):
                                                             0/85, 0/50, 0/50, 1/50 (2%) (M);
                                                             0/86, 0/50, 0/50, 7/50 (14%) (F)              P < 0.05; 0.1 µg/kg (F)
                                                                                                                                                                            2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126




21
22
     Table 3.2 (continued)
     Species, strain (sex)        Dosing regimen,                     Results                                           Significance                       Comments
     Duration                     Animals/group at start              Incidence and/or multiplicity of
     Reference                                                        tumours (%)
     Hamster, Syrian              Intraperitoneal injection           Skin (squamous-cell carcinomas):                                                     Purity NR
     Golden (M)                   0, 100 µg/kg bw TCDD in             Dioxane alone–0/12                                                                   6/24 animals injected with 100
     12–13 mo                     dioxane as 6 injections at 4                                                                                             µg/kg died before completion of
     Rao et al. (1988)            wk intervals (once every 4                                                                                               the 6-dose schedule of TCDD
                                  wk). An additional group                                                                                                 due to intestinal adhesions
                                  received 2 injections of 100        100 µg/kg TCDD, 6 doses–4/18 (21%)                [NS]                               along with obstruction and
                                  µg/kg TCDD. Controls                100 µg/kg TCDD, 2 doses–0/20                                                         peritonitis
                                                                                                                                                                                             IARC MONOGRAPHS – 100F




                                  received corresponding
                                  amounts of dioxane alone.
                                  12–24 animals/group
                                  Subcutaneous injection              Skin (squamous cell carcinomas):                                                     Purity NR
                                  0, 50 or 100 µg/kg bw TCDD          Dioxane alone–0/10                                                                   4/17 injected with 100 µg/
                                  in dioxane as 6 injections at                                                                                            kg died before completion of
                                  4-wk intervals (once every                                                                                               the 6-dose schedule of TCDD
                                  4 wk). Controls received                                                                                                 due to marked pulmonary and
                                  corresponding amounts of                                                                                                 hepatic congestion. Tumours
                                  dioxane alone.                      50 µg/kg TCDD–0/10                                [NS]                               were moderately differentiated
                                  10 or 17 animals/group              100 µg/kg TCDD–3/14 (21%)                                                            squamous-cell carcinomas that
                                                                                                                                                           developed exclusively in the
                                                                                                                                                           facial skin

     d, day or days; F, female; M, male; mo, month or months; NR, not reported; NS, not significant; ppb, part per billion; ppt, part per trillion; wk, week or weeks
Table 3.3 Studies on 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) administered with known carcinogens or modifying
     factors

     Species, strain (sex),     Known carcinogen            Route of       Interval            Dose and frequency                          Route of                Tumour
     duration, reference                                    administration                     (times per week/number of weeks)            administration          promotion
     Liver tumour
     promotion
     Han/Wistar rats (F)        30 mg/kg bw NDEA            i.p.                35 d           170 μg/kg bw TCDD/weekly/20 wk              s.c.                    +
     Duration (NR)              Starting 5 wk after PH                                         Purity > 99%
     Viluksela et al. (2000)
     Mammary gland
     tumour promotion
     SD rats (F)                30 mg/kg bw DMBA in         oral                N/A            1 μg/kg bw TCDD in sesame oil in            oral                    +
     Brown et al. (1998)        sesame oil (to 50-d-old                                        pregnant F on Day 15 p.c.
                                offspring)
     Ovarian tumour
     promotion
     SD rats (F)                175 mg/kg bw NDEA           i.p.                14 d           1.75 µg/kg bw TCDD in corn oil,             oral                    +
     Davis et al. (2000)        in saline                                                      twice/wk for 60 wk
                                175 mg/kg bw NDEA           i.p.                18 wk          1.75 µg/kg bw TCDD in corn oil,             oral                    +
                                in saline                                                      twice/wk for 30 wk followed by
                                                                                               vehicle for 16 wk
     bw, body weight; d, day or days; DMBA, 7,12-dimethylbenz[a]anthracene; F, female; i.p., intraperitoneal injection; M, male; mo, month or months; N/A, not applicable; NDEA,
     N-nitrosodiethylamine; NR, not reported; p.c., post-conception; PH, partial hepatectomy; s.c., subcutaneous injection; SD, Sprague-Dawley; wk, week or weeks
                                                                                                                                                                                   2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126




23
24
     Table 3.4 Carcinogenicity and initiation-promotion studies in experimental animals exposed to
     2,3,4,7,8-pentachlorodibenzofuran (PeCDF) and 3,3′,4,4′,5-pentachlorobiphenyl (PCB 126)

     Species, strain (sex)      Dosing regimen,                   Incidence and/or mutiplicity of            Significance           Comments
     Duration                   Animals/group at start            tumours (%)
     Reference
     PeCDF
     Rats, Harlan (F)           Groups of 81 female rats were     Liver:                                                            Purity > 97%.
     105 wk                     given 0, 6, 20, 44, 92, or 200    Hepatocellular adenomas–                                          Survival of dosed groups was
     NTP (2006b)                ng PeCDF/kg bw in corn-oil/                                                                         similar to that of the vehicle-
                                                                  1/53 (2%), 0/53, 1/53 (2%), 0/52, 2/53     P = 0.006 (trend)
                                acetone (99:1) by gavage, 5 d                                                                       control group.
                                                                                                                                                                      IARC MONOGRAPHS – 100F




                                                                  (4%), 4/53 (8%), 1/50 (2%)
                                per wk, for up to 105 wk. A
                                stop-exposure group of 50         Cholangiocarcinomas–
                                female rats was administered      0/53, 0/53, 0/53, 1/52 (2%), 1/53 (2%),    P = 0.036 (trend)
                                200 ng/kg PeCDF in corn-oil/      2/53 (4%), 0/50
                                acetone (99:1) by gavage for      Mammary gland (carcinomas):
                                30 wk and then the vehicle for
                                the remainder of the study.       5/53 (9%), *12/53 (23%), **13/53 (24%),    *P = 0.036
                                8–10 rats per group were          2/53 (4%), 5/53 (9%), 3/53 (6%)            **P = 0.021
                                evaluated at 14, 31, and 53 wk.                                              P = 0.021 (trend,
                                Controls received corn-oil.                                                  negative)

     Mice, HRS/J hairless (F)   Skin application of 5 µmol        Skin (papillomas):
     21 wk                      MNNG in 50 µL acetone             1/19 (5%); 9/19 (47%); 11/18 (61%); 8/18   P < 0.05 (all PeCDF-
     Hébert et al. (1990)       followed one wk later by          (44%)                                      treated groups)
                                application with 0 (control),
                                25, 50 or 100 ng PeCDF in
                                25 µL acetone twice a wk for
                                20 wk
                                20 animals/group
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27
Dioxin like 100_f-27

More Related Content

What's hot

Lányi_K_PhD_theses_2002
Lányi_K_PhD_theses_2002Lányi_K_PhD_theses_2002
Lányi_K_PhD_theses_2002
Katalin Lányi
 
1-s2.0-S1011134414003510-main
1-s2.0-S1011134414003510-main1-s2.0-S1011134414003510-main
1-s2.0-S1011134414003510-main
Avinash Gandi
 
Degradation of poly-L-lactide. Part 1, IMechE, 2004
Degradation of poly-L-lactide. Part 1, IMechE, 2004Degradation of poly-L-lactide. Part 1, IMechE, 2004
Degradation of poly-L-lactide. Part 1, IMechE, 2004
Dr Neill Weir
 
Research from a bacterium bacillus subtilis b 3157 by fab
Research from a bacterium bacillus subtilis b 3157 by fabResearch from a bacterium bacillus subtilis b 3157 by fab
Research from a bacterium bacillus subtilis b 3157 by fab
Alexander Decker
 
Odap chromatgrphy
Odap chromatgrphyOdap chromatgrphy
Odap chromatgrphy
Ravi Teja
 
Biodegradability potential of settleable dqo
Biodegradability potential of settleable dqoBiodegradability potential of settleable dqo
Biodegradability potential of settleable dqo
Edgar Rojas
 

What's hot (19)

5453 7562-1-pb
5453 7562-1-pb5453 7562-1-pb
5453 7562-1-pb
 
Preparation , characterization and antimicrobial activities of mixed ligand c...
Preparation , characterization and antimicrobial activities of mixed ligand c...Preparation , characterization and antimicrobial activities of mixed ligand c...
Preparation , characterization and antimicrobial activities of mixed ligand c...
 
applied catalysis A: general
applied catalysis A: generalapplied catalysis A: general
applied catalysis A: general
 
Rapid Process Development Using Design of Experiments
Rapid Process Development Using Design of ExperimentsRapid Process Development Using Design of Experiments
Rapid Process Development Using Design of Experiments
 
Rosa_PhD
Rosa_PhDRosa_PhD
Rosa_PhD
 
1 s2.0-s0272884213017057-main
1 s2.0-s0272884213017057-main1 s2.0-s0272884213017057-main
1 s2.0-s0272884213017057-main
 
Selected Research Topics
Selected Research TopicsSelected Research Topics
Selected Research Topics
 
Lányi_K_PhD_theses_2002
Lányi_K_PhD_theses_2002Lányi_K_PhD_theses_2002
Lányi_K_PhD_theses_2002
 
1-s2.0-S1011134414003510-main
1-s2.0-S1011134414003510-main1-s2.0-S1011134414003510-main
1-s2.0-S1011134414003510-main
 
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...
 
Degradation of poly-L-lactide. Part 1, IMechE, 2004
Degradation of poly-L-lactide. Part 1, IMechE, 2004Degradation of poly-L-lactide. Part 1, IMechE, 2004
Degradation of poly-L-lactide. Part 1, IMechE, 2004
 
F0412026036
F0412026036F0412026036
F0412026036
 
Cv
Cv Cv
Cv
 
Research from a bacterium bacillus subtilis b 3157 by fab
Research from a bacterium bacillus subtilis b 3157 by fabResearch from a bacterium bacillus subtilis b 3157 by fab
Research from a bacterium bacillus subtilis b 3157 by fab
 
Odap chromatgrphy
Odap chromatgrphyOdap chromatgrphy
Odap chromatgrphy
 
Determination of 8-Hydroxy-2 Deoxyguanosine in Pseudomonas Fluorescens Freeze...
Determination of 8-Hydroxy-2 Deoxyguanosine in Pseudomonas Fluorescens Freeze...Determination of 8-Hydroxy-2 Deoxyguanosine in Pseudomonas Fluorescens Freeze...
Determination of 8-Hydroxy-2 Deoxyguanosine in Pseudomonas Fluorescens Freeze...
 
Newkome1981
Newkome1981Newkome1981
Newkome1981
 
Biodegradability potential of settleable dqo
Biodegradability potential of settleable dqoBiodegradability potential of settleable dqo
Biodegradability potential of settleable dqo
 
West Nile Virus
West Nile VirusWest Nile Virus
West Nile Virus
 

Viewers also liked (14)

Vol100 f evaluations
Vol100 f evaluationsVol100 f evaluations
Vol100 f evaluations
 
Categorie
CategorieCategorie
Categorie
 
Lancet onc vol100_tables
Lancet onc vol100_tablesLancet onc vol100_tables
Lancet onc vol100_tables
 
Dioxin like
Dioxin likeDioxin like
Dioxin like
 
Dm 9 aprile 2008 nuovo elenco-malattie-professionali-gu 21 luglio2008
Dm 9 aprile 2008 nuovo elenco-malattie-professionali-gu 21 luglio2008Dm 9 aprile 2008 nuovo elenco-malattie-professionali-gu 21 luglio2008
Dm 9 aprile 2008 nuovo elenco-malattie-professionali-gu 21 luglio2008
 
A guide to diagnosis ec
A guide to diagnosis ecA guide to diagnosis ec
A guide to diagnosis ec
 
Causazione2004
Causazione2004Causazione2004
Causazione2004
 
Tabelle allegate al dm 9 aprile 2008
Tabelle allegate al dm 9 aprile 2008Tabelle allegate al dm 9 aprile 2008
Tabelle allegate al dm 9 aprile 2008
 
Malattie da denunciare_decreto 14 gennaio 2008
Malattie da denunciare_decreto 14 gennaio 2008Malattie da denunciare_decreto 14 gennaio 2008
Malattie da denunciare_decreto 14 gennaio 2008
 
Crit causal07
Crit causal07Crit causal07
Crit causal07
 
THE CONCEPT OF HYGIENE IN HUMAN LIFE
THE CONCEPT OF HYGIENE IN HUMAN LIFETHE CONCEPT OF HYGIENE IN HUMAN LIFE
THE CONCEPT OF HYGIENE IN HUMAN LIFE
 
1 hygiene introduction
1 hygiene introduction1 hygiene introduction
1 hygiene introduction
 
National health programes for non communicable disease
National health programes for non communicable diseaseNational health programes for non communicable disease
National health programes for non communicable disease
 
I cibi ed il nostro sistema immunitario - probiotici
I cibi ed il nostro sistema immunitario - probioticiI cibi ed il nostro sistema immunitario - probiotici
I cibi ed il nostro sistema immunitario - probiotici
 

Similar to Dioxin like 100_f-27

The Effect of Formic Acid, Hydrogen Peroxyde and Other Conditions on Epoxidiz...
The Effect of Formic Acid, Hydrogen Peroxyde and Other Conditions on Epoxidiz...The Effect of Formic Acid, Hydrogen Peroxyde and Other Conditions on Epoxidiz...
The Effect of Formic Acid, Hydrogen Peroxyde and Other Conditions on Epoxidiz...
ijtsrd
 
Hp Uiuc Part2
Hp Uiuc Part2Hp Uiuc Part2
Hp Uiuc Part2
zirbruno
 
Chemosphere publication
Chemosphere publicationChemosphere publication
Chemosphere publication
Roger Dailey
 
DNAPL Remediation with ClO2_UV-published paper
DNAPL Remediation with ClO2_UV-published paperDNAPL Remediation with ClO2_UV-published paper
DNAPL Remediation with ClO2_UV-published paper
Darcy Bye
 
Operational parameters affecting the removal and recycling of direct blue ind...
Operational parameters affecting the removal and recycling of direct blue ind...Operational parameters affecting the removal and recycling of direct blue ind...
Operational parameters affecting the removal and recycling of direct blue ind...
IJEAB
 

Similar to Dioxin like 100_f-27 (20)

plastic waste management 226 a perspective
plastic waste management  226 a perspectiveplastic waste management  226 a perspective
plastic waste management 226 a perspective
 
Determination of ultralevels.pdf
Determination of ultralevels.pdfDetermination of ultralevels.pdf
Determination of ultralevels.pdf
 
Determination of ultralevels.pdf
Determination of ultralevels.pdfDetermination of ultralevels.pdf
Determination of ultralevels.pdf
 
plastic waste management 226 a perspective
plastic waste management  226 a perspectiveplastic waste management  226 a perspective
plastic waste management 226 a perspective
 
New strategy for analysis of PCDF.pdf
New strategy for analysis of PCDF.pdfNew strategy for analysis of PCDF.pdf
New strategy for analysis of PCDF.pdf
 
Morosini 2001 Correlation Between C-6/C-14 Chlorinated Hydrocarbons Levels in...
Morosini 2001 Correlation Between C-6/C-14 Chlorinated Hydrocarbons Levels in...Morosini 2001 Correlation Between C-6/C-14 Chlorinated Hydrocarbons Levels in...
Morosini 2001 Correlation Between C-6/C-14 Chlorinated Hydrocarbons Levels in...
 
BIODEGRADATION OF ORGANIC POLLUTANTS
BIODEGRADATION OF ORGANIC POLLUTANTSBIODEGRADATION OF ORGANIC POLLUTANTS
BIODEGRADATION OF ORGANIC POLLUTANTS
 
The Effect of Formic Acid, Hydrogen Peroxyde and Other Conditions on Epoxidiz...
The Effect of Formic Acid, Hydrogen Peroxyde and Other Conditions on Epoxidiz...The Effect of Formic Acid, Hydrogen Peroxyde and Other Conditions on Epoxidiz...
The Effect of Formic Acid, Hydrogen Peroxyde and Other Conditions on Epoxidiz...
 
Distribution of polychlorinated biphenyls in surface waters of various source...
Distribution of polychlorinated biphenyls in surface waters of various source...Distribution of polychlorinated biphenyls in surface waters of various source...
Distribution of polychlorinated biphenyls in surface waters of various source...
 
11.distribution of polychlorinated biphenyls in surface waters of various sou...
11.distribution of polychlorinated biphenyls in surface waters of various sou...11.distribution of polychlorinated biphenyls in surface waters of various sou...
11.distribution of polychlorinated biphenyls in surface waters of various sou...
 
synthesis and spectral studies on cardanol based polyurethanes
synthesis and spectral studies on cardanol based polyurethanessynthesis and spectral studies on cardanol based polyurethanes
synthesis and spectral studies on cardanol based polyurethanes
 
Hp Uiuc Part2
Hp Uiuc Part2Hp Uiuc Part2
Hp Uiuc Part2
 
Microwave assisted synthesis and IR spectral analysis of a few complexes of 4...
Microwave assisted synthesis and IR spectral analysis of a few complexes of 4...Microwave assisted synthesis and IR spectral analysis of a few complexes of 4...
Microwave assisted synthesis and IR spectral analysis of a few complexes of 4...
 
Eurosurfas 2011: Jornadas Medioambiente - Amparo Cortes
Eurosurfas 2011: Jornadas Medioambiente - Amparo CortesEurosurfas 2011: Jornadas Medioambiente - Amparo Cortes
Eurosurfas 2011: Jornadas Medioambiente - Amparo Cortes
 
Nanocrystalline Nickel Zinc Ferrite as an efficient alcohol sensor at room te...
Nanocrystalline Nickel Zinc Ferrite as an efficient alcohol sensor at room te...Nanocrystalline Nickel Zinc Ferrite as an efficient alcohol sensor at room te...
Nanocrystalline Nickel Zinc Ferrite as an efficient alcohol sensor at room te...
 
Chemosphere publication
Chemosphere publicationChemosphere publication
Chemosphere publication
 
DNAPL Remediation with ClO2_UV-published paper
DNAPL Remediation with ClO2_UV-published paperDNAPL Remediation with ClO2_UV-published paper
DNAPL Remediation with ClO2_UV-published paper
 
A convenient new and efficient commercial synthetic route for dasatinib (Spry...
A convenient new and efficient commercial synthetic route for dasatinib (Spry...A convenient new and efficient commercial synthetic route for dasatinib (Spry...
A convenient new and efficient commercial synthetic route for dasatinib (Spry...
 
Steve DeVito: Green Chemistry Practices in the Pharmaceutical Industry
Steve DeVito: Green Chemistry Practices in the Pharmaceutical IndustrySteve DeVito: Green Chemistry Practices in the Pharmaceutical Industry
Steve DeVito: Green Chemistry Practices in the Pharmaceutical Industry
 
Operational parameters affecting the removal and recycling of direct blue ind...
Operational parameters affecting the removal and recycling of direct blue ind...Operational parameters affecting the removal and recycling of direct blue ind...
Operational parameters affecting the removal and recycling of direct blue ind...
 

Recently uploaded

Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
vineshkumarsajnani12
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
ZurliaSoop
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
daisycvs
 

Recently uploaded (20)

New 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck TemplateNew 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck Template
 
Falcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business GrowthFalcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business Growth
 
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTSDurg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with Culture
 
Kalyan Call Girl 98350*37198 Call Girls in Escort service book now
Kalyan Call Girl 98350*37198 Call Girls in Escort service book nowKalyan Call Girl 98350*37198 Call Girls in Escort service book now
Kalyan Call Girl 98350*37198 Call Girls in Escort service book now
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
 
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All TimeCall 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
 
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
 
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur DubaiUAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
 

Dioxin like 100_f-27

  • 1. 2,3,7,8-TETRACHLORODIBENZO- para-DIOXIN, 2,3,4,7,8-PENTACHLORODIBENZOFURAN, AND 3,3′,4,4′,5-PENTACHLOROBIPHENYL Two of these agents (2,3,7,8-tetrachlorodibenzo-para-dioxin and 2,3,4,7,8-pentachloro- dibenzofuran were specifically considered by previous IARC Working Groups in 1977, 1987, and 1997 (IARC, 1977, 1987, 1997). The Working Group in 1987 reviewed polychlorinated biphenyls, but did not specifically consider 3,3′,4,4′,5-pentachlorobiphenyl. Since the previous evaluations new data have become available, which have been incorporated in this Monograph and taken into consideration in the present evaluation. 1. Exposure Data Description: Colourless to white crystalline solid Solubility: Insoluble in water; slightly 1.1 Identification of the agents soluble in n-octanol and methanol; and From NTP (2006a, b, c) soluble in other organic solvents (e.g. dichlorobenzene, chlorobenzene, benzene, 1.1.1 2,3,7,8-Tetrachlorodibenzo-para-dioxin chloroform, and acetone) (2,3,7,8-TCDD, TCDD) Octanol/water partition coefficient: Chem. Abstr. Serv. Reg. No.: 1746-01-6 log Kow, 6.80 Chem. Abstr. Serv. Name: 2,3,7,8-Tetrachlorodibenzo[b,e][1,4]dioxin 1.1.2 2,3,4,7,8-pentachlorodibenzofuran Synonyms: 2,3,7,8-TCDD; TCDD; dioxin; (2,3,4,7,8-PeCDF) tetradioxin Chem. Abstr. Serv. Reg. No.: 57117-31-4 Cl O Cl Chem. Abstr. Serv. Name: 2,3,4,7,8-Pentachlorodibenzofuran Synonym: 2,3,4,7,8-PeCDF; Cl O Cl 2,3,4,7,8-penta-CDF C12H4Cl4O2 Relative molecular mass: 321.98 1
  • 2. IARC MONOGRAPHS – 100F Cl 1.2 Occurrence and use Cl O Cl 2,3,7,8-Tetrachlorodibenzo-para-dioxin (TCDD) has no known commercial applications. It occurred as a contaminant in chlorophenoxy Cl Cl herbicides, including 2,4,5-trichlorophenoxy- C12H3Cl5O acetic acid (2,4,5-T), which were widely used Relative molecular mass: 340.42 in the 1960s and 1970s to control weeds (e.g. Description: Solid with a melting point of on pastureland and food crops) and as a defo- 195–196 °C (NTP Chemical Repository liant during the Viet Nam war. It is used as a Information). It is stable under normal research chemical and was tested, but never used laboratory conditions. commercially, as a flame-proofing agent and as Solubility in water: 2.36 × 10−4 mg/L at a pesticide against insects and wood-destroying 22.7 °C fungi (NTP, 2004). Octanol/water partition coefficient: Polychlorinated dibenzofurans (PCDFs) are log Kow, 6.92 not manufactured commercially other than for scientific research purposes. Release of PCDF into the environment is mainly from combus- 1.1.3 3,3′,4,4′,5-pentachlorobiphenyl tion and incineration. Based on congener- (PCB 126) specific profiles, combustion sources all produce Chem. Abstr. Serv. Reg. No.: 57465-28-8 2,3,7,8-substituted polychlorinated dibenzo- Chem. Abstr. Serv. Name: para-dioxins (PCDDs) and PCDFs, including 3,3′,4,4′,5-Pentachlorobiphenyl 2,3,4,7,8-pentachlorodibenzofuran (PeCDF). The Synonym: PCB 126 latter substance is the major congener emitted Cl from cement kilns burning hazardous waste (approximately 20% of the total congener emis- sion). Other major sources of PeCDF are metal Cl Cl smelting, refining, and processing; chemical manufacturing/processing (production of chlo- Cl Cl rophenols, PCBs, vinyl chloride); pulp bleaching; and existing reservoirs that reflect past releases C12H5Cl5 (IARC, 1997; USEPA, 2000a). Relative molecular mass: 326.42 Mixtures of polychlorobiphenyls (PCBs), Description: Solid with a melting point of including 3,3′,4,4′,5-pentachlorobiphenyl (PCB 160–161 °C. 126), were produced for commercial purposes Solubility in water: 1.03 × 10−3 mg/L at during the period 1929–1977 for the electrical 25 °C industry, to be used as dielectric insulating Octanol/water partition coefficient: fluids for transformers and capacitors. PCBs log Kow, 6.89 were also used in hydraulic fluids, plastics, and paints. The manufacture and use of PCBs in the United States was stopped in 1977 in view of increasing amounts of PCB residues in the environment that had accumulated during the previous decades. However, PCBs continue to be 2
  • 3. 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 released into the environment through the use lipid]. Available data suggest that these levels have and disposal of products containing PCBs, as decreased three- to fivefold since the late 1970s, by-products during the manufacture of certain when the development of gas chromatography/ organic chemicals, and during combustion of mass spectrometry methodology permitted some waste materials (USEPA, 2000a). Due to these extremely low concentrations of TCDD in their lipophilic nature (log Kow, 6.5–7.7) and tissues and in the environment to be measured resistance to biodegradation, specific PCBs bio- accurately for the first time. Similarly, since the concentrate and bio-accumulate in the environ- mid-1980s, mean tissue concentrations of total ment. PCBs are widespread in their distribution TCDD in the general population have decreased and are found in virtually all environmental by two- to threefold. Human exposures related compartments including air, soil, water, sedi- to occupation or accidents have led to tissue ment, and biota (USEPA, 2000b). concentrations of TCDD up to several orders of magnitude higher than background levels (IARC, 1997). 1.3 Human exposure Polychlorinated dibenzo-para-dioxins 1.3.1 Occupational exposure to dioxins (PCDDs), including TCDD, are formed as inad- Because TCDD has never been intentionally vertent by-products during the production of manufactured for large-scale commercial use, chlorophenols and chlorophenoxy herbicides, estimates of the numbers of workers exposed in and have been detected as contaminants in the past are not available. From the US National these products. TCDD may also be produced Occupational Exposure Survey (1981–1983), it in thermal processes such as incineration, in was estimated that approximately 14 workers metal-processing, and in the bleaching of paper were potentially exposed to TCDD in the USA pulp with free chlorine. The relative amounts of (NIOSH, 1990). Historical occupational expo- the TCDD congeners produced depend on the sures to TCDD have been reviewed (IARC, 1997). production or incineration process and vary In a series of studies, Collins et al. (2006, widely (IARC, 1997). 2007, 2008) examined concentrations of TCDD PCDDs are ubiquitous in soil, sediments and in serum from 375 workers in Michigan who had air. Excluding occupational or accidental expo- been exposed in the past (26–62 years before) sures, most human exposure to TCDD occurs to trichlorophenol and/or pentachlorophenol. as a result of eating meat, milk, eggs, fish and Workers exposed only to trichlorophenol had related products, as TCDD is persistent in the mean lipid-adjusted TCDD levels of 15.9 ppt, environment and accumulates in animal fat. compared with 6.5 ppt in unexposed workers and Occupational exposures to TCDD at higher 3.3 ppt in community controls. Those exposed levels have occurred since the 1940s as a result of to pentachlorophenol only had mean TCDD production and use of chlorophenols and chlo- concentrations of 8.0 ppt; workers exposed to rophenoxy herbicides. Even higher exposures both chemicals had mean TCDD levels of 13.9 have occurred sporadically in relation to acci- ppt; and tradesmen with plant-wide responsi- dents in these industries (IARC, 1997). bilities had mean levels of 20.7 ppt. A follow- Mean background levels of TCDD in human up study to evaluate the influence of various tissues are in the range of 2–3 ng/kg (parts per factors on TCDD concentrations in serum of 412 trillion; ppt) fat [because PCDDs are stored in workers exposed to penta- and trichlorophenol, fat tissue, body burdens of PCDDs are often showed that age and body fat were important expressed as concentration in lipid, e.g. 100 ppt 3
  • 4. IARC MONOGRAPHS – 100F determinants, whereas diet and jobs-outside- 62.4 ng/kg for the two control groups (Ryan & the-plant had little impact (Burns et al., 2008). Schecter, 2000). To estimate job-specific exposures over time Several exposure-response analyses have been at a facility in New Zealand that manufactured performed in the industrial cohorts that served 2,4,5-T along with other products between 1962 as a basis for the previous IARC Monographs and 1988, Aylward et al. (2010) integrated avail- evaluation (Becher et al., 1998; Flesch-Janys et al., able work records, TCDD pharmacokinetic data, 1998; Hooiveld et al., 1998; Steenland et al., 1999, and serum-sampling data from 346 workers. 2004; Crump et al., 2003). Estimated TCDD concentrations in serum were below 300 ppt lipid for all individuals in the 1.3.2 Non-occupational exposure to dioxins cohort over the entire study period, i.e. lower than estimates for other 2,4,5-T worker populations. PCDDs, including TCDD, have been measured McLean et al. (2009) measured dioxin concen- in all environmental compartments including trations in serum of 94 randomly selected former ambient air, surface water, groundwater, soil, sawmill workers (71 exposed to pentachloroph- and sediment. While the manufacture and use of enol, 23 non-exposed) in New Zealand, twenty chlorinated compounds – chlorophenols, chlo- years after the use of pentachlorophenol (PCP) rinated phenoxy herbicides – were important had ceased. The authors compared age-adjusted sources of PCDD-release into the environment dioxin levels in the exposed and non-exposed in the past, the restricted manufacture of many groups, examined the effect of duration and of these compounds has substantially reduced intensity of the exposure to PCP, and compared their contribution to environmental pollution. congener profiles with those found in the commer- It is now recognized that incineration/combus- cial-grade PCP used at the time. Mean levels in tion processes are the most important sources exposed and unexposed workers were 1.88 pg/g of PCDDs to the environment (Zook & Rappe, (range, 0.51–4.13) and 1.48 pg/g, respectively. 1994; ATSDR, 1998). The congener profiles in serum were consistent The identified sources of environmental with those in PCP solutions, and dioxin levels release of TCDDs have been grouped into four increased with both employment duration and major categories: incineration sources (munic- estimated exposure intensity. ipal waste, hospital waste, hazardous waste, In a study of Russian workers who manu- sewage sludge), combustion sources (cement factured phenoxy herbicides and related kilns, wood-burning, diesel vehicles, coal-fired compounds in the 1960s, workers who handled utilities, crematoria), industrial sources (pulp 2,4,5-T (n = 34) had median blood-lipid TCDD and paper mills, chemical manufacturing, metal concentrations of 165.7 ng/kg (parts per trillion), industry), and reservoir sources (biochemical with a range from 35 to 1680 ng/kg. Workers who processes, photolytic processes, forest fires, acci- manufactured 2,4-dichlorophenoxyacetic acid dental releases) (Kulkarni et al., 2008). (2,4-D; n = 6) had median levels of 68.9 ng/kg. Human exposure to all dioxin-like Children of workers who handled 2,4,5,-T (n = 8) compounds is usually calculated in terms of and administrative workers (n  =  5) had higher toxic equivalence quotients (TEQs). median levels than two control groups drawn Because the various polychlorinated dibenzo- from the general population (n = 60): the median p-dioxins, polychlorinated dibenzofurans, and polychlorinated biphenyls have different blood-lipid TCDD concentrations in the chil- activity levels, a toxic equivalence quotient dren and administrative staff were 39.5 and (TEQ) is calculated by standardizing the indi- 31.0 ng/kg, respectively, compared with 12 and vidual congener levels detected in each sample, 4
  • 5. 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 multiplying them with the appropriate toxic There is evidence from the NHANES serum equivalency factor (TEF), and summing these PCDD/F data (including TCDD) that concentra- normalized values. TEFs have been established tions of these compounds in the US population by the World Health Organization and are calculated relative to 2,3,7,8-TCDD (Van den are declining. Median serum-lipid concentra- Berg et al., 2006; Charnley & Kimbrough, 2006; tions (population-weighted) of PCDDs/Fs were see also Section 4). 13.46, 13.98 and 11.39 TEQ/g lipid for 1999–2000 The US Environmental Protection Agency (n = 1271), 2001–2002 (n = 1244), and 2003–2004 (USEPA) reported that emissions from quan- (n  =  1290), respectively. When the temporal tified sources – waste incineration, pesticide trends are examined by age, median levels appear manufacture, chlorine bleaching of pulp and to have declined in the younger part of the popu- paper – in the USA decreased from about 14 000 lation and remained essentially constant (or have g TEQ/year in 1987 to approximately 1500 g slightly increased) in the older part (LaKind TEQ/year in 2000 (a 90% reduction). This decline et al., 2009). is expected to continue (Charnley & Kimbrough, Several exposure studies have shown that 2006; USEPA, 2006). some US Viet Nam veterans who were exposed to People are exposed to PCDDs primarily Agent Orange had serum TCDD levels up to 600 through foods that are contaminated as a result of ppt in lipid many years after they had left Viet the accumulation of these substances in the food- Nam, compared with values of approximately 1–2 chain and in high-fat foods, such as dairy prod- ppt of TCDD for the general population (Kahn ucts, eggs, animal fats, and some fish. Additional et al., 1988; Schecter et al., 1990, 1992; Michalek exposure sources include industrial accidents et al., 1995). In Viet Nam, TCDD levels up to (Baccarelli et al., 2002) and several miscellaneous 1  000  000 ppt have been found in soil or sedi- exposures (Yoshimura, 2003; Kulkarni et al., ment from Agent Orange-contaminated areas 2008). Because dioxins are fat-soluble, lowering 3–4 decades after spraying. In addition, elevated the fat content in food can reduce the intake of concentrations have been measured in food and dioxin. The average adult in the USA has a daily wildlife in Viet Nam (Olie et al., 1989) as well as TEQ intake of approximately 1 pg/kg, lower in Vietnamese people from contaminated areas than a decade ago, whereas a nursing infant has (Schecter et al., 2001, 2002, 2003; Dwernychuk an average TEQ intake of 35–53 pg/kg bw/day et al., 2002; Schecter et al., 2006). (Schecter et al., 1994; USEPA, 2004; Schecter Bates et al. (2004) determined persistent orga- et al., 2006). nochlorines, including TCDD, in serum of the Data on TCDD concentrations in lipids have non-occupationally exposed New Zealand popu- been collected over a 30-year period (1970–2000) lation in 1996–1997. The weighted mean concen- among the general population in the USA, tration of TCDD in adult New Zealanders was Canada, Germany, and France. Mean lipid- 2.3 ng/kg lipid weight basis (range, < 1–7.0 ng/kg). levels of TCDD steadily decreased nearly 10-fold The age group-specific data showed a trend over this time period, with lipid-adjusted TCDD towards higher concentrations in the older age concentratrions of about 2 ppt in the year 2000. groups. On the basis of pharmacokinetic modelling, Several recent studies have assessed and mean concentrations of TCDD in the general reviewed the exposure to and intake of dioxins, population are likely to decrease further to 0.5–1 including TCDD, from dietary sources (Liem ppt by 2015, even if intake levels do not decrease et al., 2000; Tsutsumi et al., 2001; Huwe, 2002; further (Aylward & Hays, 2002; Hays & Aylward, Parzefall, 2002; Baars et al., 2004; Charnley & 2003). Doull, 2005; Nakatani et al., 2005; Larsen, 2006; 5
  • 6. IARC MONOGRAPHS – 100F Sasamoto et al., 2006; Gies et al., 2007; Todaka European tissue samples, PeCDF levels are on et al., 2008). average 13 ppt TEQ (lipid-adjusted) and repre- sent approximately 36% of the TEQ contributed 1.3.3 Human exposure to polychlorinated by PCDDs and PCDFs. PeCDF is the highest dibenzofurans, polychlorinated contributor of the PCDF class of DLCs to the biphenyls and dioxin-like compounds total TEQ, based on both intake levels and tissue concentrations. Due to high lipophilicity and low solubility in The majority (90%) of ambient human expo- aqueous media, polychlorinated dibenzofurans sure to dioxin-like compounds occurs through (PCDFs) accumulate in the fat tissue of animals. the ingestion of food containing PCB residues. The highest concentrations of PCDFs are found Levels of PCB 126 in food range from 0.05 to in fish, meat, eggs, and dairy products (Schecter 0.83 pg/g. Human exposure to all dioxin-like et al., 1994; USEPA, 2000b). This results in compounds is usually calculated in terms of toxic widespread exposure of the general population equivalents (TEQs). On a TEQ basis, it is esti- to PCDFs and related dioxin-like compounds, mated that humans are exposed via food to 22 pg with an estimated 90% of human exposure due TEQ/day (for a 70-kg person) from dioxin-like to ingestion of contaminated food, and a small PCBs of which PCB 126 (13 pg/day) accounts for fraction via inhalation and dermal absorption. 60% of the TEQ intake. Bioaccumulation of PCBs Human exposure to all dioxin-like results in persistent levels of these substances in compounds is usually calculated in terms of human tissues. With an average concentration of TEQs (see definition above). Adult daily intake 12 pg TEQ/g lipid, PCB 126 accounts for approxi- of dioxin-like compounds including PCDDs, mately half of the PCB TEQ in human tissues PCDFs and dioxin-like PCBs from all sources (USEPA, 2000b). is estimated to be approximately 70pg TEQ/day, where TEQ reflects the potency-adjusted amount of all dioxin-like compounds. The intake from all 2. Cancer in Humans sources of PCDDs and PCDFs is estimated to be 45pg TEQ/day and intake from dioxin-like PCBs Human exposures related to occupation or is 25pg TEQ/day. Approximately 90% of the daily accidents have led to tissue concentrations of intake is from food sources (40pg TEQ/day for 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) PCDDs and PCDFs and 22pg TEQ/day for dioxin- that are 10–100-fold higher than average back- like PCBs). Intake of PeCDF from food is approx- ground levels in the 1980s. The highest expo- imately 6.6 pg per day and represents 16% of the sures occurred in industrial cohorts of workers total intake of PCDDs and PCDFs on a TEQ basis. producing phenoxy herbicides and chloroph- This level of exposure together with the long half- enols, while exposure to professional sprayers life of dioxin-like compounds in humans leads to of these compounds was considerably lower. It persistent body burdens in humans in the range has been shown that TCDD levels in professional of 25 pg TEQ/g lipid (USEPA, 2000b). Depending applicators increase considerably above back- upon dietary practice and proximity to specific ground only after several years of spraying of sources of exposure, some populations may have TCDD-contaminated chemicals. For example, in higher exposure or body burdens. In contrast to the most heavily exposed applicators of 2,4,5-T the general population, several specific groups in New Zealand, who applied this chemical may have been exposed to much higher levels of for at least 180 months, the estimated mean PeCDF as a result of occupational exposure. In 6
  • 7. 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 serum concentration of TCDD at the time of industrial cohorts, many of them not reported in blood drawing was 53 ng/kg (Smith et al., 1992). separate publications, as well as information on Occasional spraying is unlikely to lead to any professional applicators. Most of the industrial measurable increase in TCDD level. cohort studies include analyses of subcohorts The evaluation of the evidence of carcino- considered to have the highest exposure and/or genicity of TCDD was based on studies with longest latency. These cohorts and their respec- direct measurements of TCDD and studies tive high-exposure subcohorts are the focus involving heavy exposure to herbicides likely of this evaluation. In reporting the findings, to be contaminated with TCDD. There are preference has been given to the most updated numerous studies that assessed dioxins, furans follow-up, unless earlier publications presented and polychlorobiphenyls (PCBs) in workers, but evidence not included in a later publication, e.g. these are not systematically reviewed here. These results by exposure classifications of interest. studies indicate that the highest exposure occurs Additional studies of herbicide applicators, both in industrial settings producing 2,4,5-T. There cohort and case–control studies, which have are also numerous studies in workers evaluating considerably lower exposures to TCDD, are not a wide range of health effects. Table 2.1 (available considered critical for the evaluation and are not at http://monographs.iarc.fr/ENG/Monographs/ reported in Table  2.2 (available at http://mono- vol100F/100F-22-Table2.1.pdf) shows estimated graphs.iarc.fr/ENG/Monographs/vol100F/100F- exposures to TCDD in industrial workers, in 22-Table2.2.pdf), Table  2.3 (available at http:// workers handling and spraying 2,4,5-T and in the mono g r aph s . i a rc . f r/ E NG/ Mono g r a ph s / population in Seveso, Italy. Average exposures in vol100F/100F-22-Table2.3.pdf), Table  2.4 industrial workers are the highest. The effects of (available at http://monographs.iarc.fr/ENG/ TCDD and those of the products in which it was Monographs/vol100F/100F-22-Table2.4.pdf ), found cannot be separated in most of the epide- or Table  2.5 (available at http://monographs. miological studies; however, the focus here is on iarc.fr/ENG/Monographs/vol100F/100F-22- the contaminant. The most important studies for Table2.5.pdf). Among the studies not included, the evaluation of the carcinogenicity of TCDD there are several that have been widely quoted are cohort studies of herbicide producers, one and that have been important in responding to each in the United States (Fingerhut et al., 1991; concerns in the community and in raising public Steenland et al., 1999, 2001), the Netherlands awareness regarding potential effects of dioxin (Bueno de Mesquita et al., 1993; Hooiveld et al., exposure, such as Ketchum & Aktar (1996), 1998; Boers et al. 2010), two in Germany (Manz Ketchum et al. (1999), and Hardell & Sandström et al., 1991; Ott et al., 1993; Flesch-Janys et al., 1995, (1979). 1998; Becher et al., 1996), and one cohort of resi- dents in a contaminated area from Seveso, Italy (Bertazzi et al., 2001; Pesatori et al., 2009). These 2.1 Description of the most studies involve the highest exposures to TCDD informative studies among all epidemiological studies, although the 2.1.1 US NIOSH cohort exposures at Seveso were lower and the follow-up was shorter than those in the industrial settings. The largest study of production workers in In addition, the multicountry cohort study from the US exposed to PCDDs was conducted by the IARC (Saracci et al., 1991; Kogevinas et al., 1995, National Institute for Occupational Safety and 1997) is of special interest because it includes Health (NIOSH) and published by Fingerhut et three of four high-exposure cohorts and other al. (1991) and Steenland et al. (1999, 2001). This 7
  • 8. IARC MONOGRAPHS – 100F 12-plant cohort study included most workers in detailed individual job histories. Two nested the USA likely to have been exposed to TCDD case–control studies of soft-tissue sarcoma and in chemical manufacturing, comprising 5000 non-Hodgkin lymphoma were conducted by men with work records showing assignment to Kogevinas et al. (1995). The international cohort a production or maintenance job in a process studied by Saracci et al. (1991) was updated involving TCDD contamination. Serum levels and expanded with the data of Fingerhut et al. of TCDD in 253 cohort members at two plants (1991), Becher et al. (1996), and Kogevinas et al. measured in 1987 averaged 233 ng/g lipid, (1997). TCDD was measured in serum samples compared with 7 ng/g lipid in a group of 79 unex- for workers in Germany, the Netherlands and the posed workers. Levels increased to 418 ng/kg for USA. Results from cohorts in specific countries 119 workers exposed for more than one year. have been published separately (Coggon et al., Estimates of TCDD exposure were based on 1991; Lynge, 1993). occupational records, on an exposure matrix based on industrial hygiene measurements, 2.1.4 German cohorts and on modelling based on measured TCDD in serum samples. A series of publications on two Several reports have considered workers separate plants were available (Zack & Suskind, from a chemical plant operated by Boehringer- 1980; Zack & Gaffey, 1983; Cook et al., 1986; Ott Ingelheim, Hamburg, Germany. This plant et al., 1987; Bond et al., 1989; Collins et al., 1993). produced herbicides heavily contaminated with TCDD and other PCDDs/PCDFs (Manz et al., 1991; Flesch-Janys et al., 1995, 1998; Becher et al., 2.1.2 German accident cohort 1996). In the latter study, workers from three In the 1953 accident at the 2,4,5-trichlo- other German plants were also considered. rophenol (TCP) production unit of BASF at TCDD analyses were done on serum samples Ludwigshafen, Germany, the total number of from the workers in the Boehringer-Ingelheim employees identified as being involved directly cohort. or in the subsequent clean-up, repair or main- tenance activities was 247 (243 men, 4 women). 2.1.5 Dutch cohorts Analyses of adipose tissue and blood from groups of these workers were conducted. Part of The mortality of two cohorts of workers the cohort was first studied by Thiess et al. (1982) employed between 1955 and 1986 in the synthesis and was completed by Ott & Zober (1996). and formulation of phenoxy herbicides and chlo- rophenols in the Netherlands has been studied (Bueno de Mesquita et al., 1993). In one of the 2.1.3 IARC multicountry study plants (A), where the production was focused An international cohort of workers exposed on 2,4,5-T and derivatives, an accident in 1963 to phenoxy herbicides and chlorophenols was set caused a release of PCDDs, including TCDD. up by the International Agency for Research on Serum samples have been analysed for the pres- Cancer, France (Saracci et al., 1991). The cohort ence of TCDD. The study has been updated included 16 863 men and 1527 women employed (Hooiveld et al., 1998; Boers et al., 2010) in production or spraying, distributed among 20 cohorts from ten countries. Exposure assessment was based on plant-production records collected in each factory through questionnaires and on 8
  • 9. 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 2.1.6 Seveso population exposed during an (NIOSH, Boehringer-Ingelheim, Germany, and industrial accident BASF, Germany) found a statistically significant (P  =  0.02) trend in total cancer mortality with On 10 July 1976, a runaway reaction led to increasing exposure to dioxin (Crump et al., a blow-out of a TCP-production reactor at the 2003). The trend tests show an increase in total ICMESA plant at Seveso, ltaly. The chemical cloud cancers at cumulative TEQ – a metric TCDD-like that was released from the reactor contained a compounds that is defined here as the amount substantial amount of TCDD. The contaminated of TCDD that would produce the same toxicity area was subdivided into Zones A and B, and as a mixture of TCDD-like compounds – serum Zone R in descending order of TCDD contami- levels that would result from lifetime intake of nation in the soil. The mortality and cancer inci- 7 pg TEQ/kg body weight/day. A linear dose– dence in the population of Seveso exposed during response provided a good fit to the combined this industrial accident were investigated. The data. There was no overall increase of cancer in the exposed and referent populations were followed- population in Seveso, with only minor increases up as if they belonged to a unique cohort, blind observed for all-cancer mortality and incidence to the exposure status of the subjects. The follow- at 15 or more years since the accident in the most up after 20 years was > 99% successful (Bertazzi heavily exposed zones. [The overall increase iden- et al., 2001; Pesatori et al., 2009) tified in all industrial cohorts, and the positive trends with increased exposure that are based on 2.2 All cancers internal comparisons, reinforce an overall posi- tive association between all cancers combined An increased risk for all cancers combined and exposure to TCDD, making it less likely that was found in the industrial cohort studies cited the increase is explained by confounding, either above in the USA, Germany, and the Netherlands by smoking or by other exposures to carcinogens and to a lesser extent in the international cohort in the industrial setting.] (see Table  2.2, online). The magnitude of the increase is generally small. It is higher in subco- horts considered to have the heaviest TCDD 2.3 Cancer of the lung exposure, e.g. the chloracne subcohort in the An increased risk for lung cancer was observed NIOSH study. Furthermore, statistically signifi- in the industrial cohort studies, especially in the cant positive dose–response trends for all cancers more highly exposed subcohorts (see Table 2.3, combined were present in the NIOSH cohort and online). The relative risk for lung cancer in the in the largest and most heavily exposed German highly exposed subcohorts was around 1.5 in cohort. A positive trend (P = 0.05) was also seen several studies. [It is possible that relative risks in the smaller German cohort where an accident of this order for lung cancer could result from occurred with release of large amounts of TCDD. confounding by smoking, but this would only However, the positive trend in this cohort was be the case if there were a pronounced differ- limited to smokers. Cumulative dose in these ence in smoking habits between the exposed and trend analyses was estimated by combining the referent populations, a difference that seems data from TCDD concentrations in blood and unlikely. Therefore, confounding by smoking information on job categories, work processes can probably not explain all the excess risk for and calendar time of exposure. A metanal- lung cancer, although it could explain part of it. ysis of data from three cohorts occupation- It is also possible that other occupational carcin- ally exposed to TCDD and related compounds ogens, many of which would affect the lung, are 9
  • 10. IARC MONOGRAPHS – 100F causing some confounding.] In Seveso, increased were mostly non-significant and below 2 (see mortality and cancer incidence for lung cancer Table  2.5, online). A case–control study nested was observed at more than 15 years since the in the IARC cohort provided weak evidence of accident. a dose–response relationship with estimated exposure to TCDD. [Although it is plausible that other chemicals cause non-Hodgkin lymphoma, 2.4 Soft-tissue sarcoma strong potential confounding factors are not An association between soft-tissue sarcoma known. The lack of complete consistency among and spraying of phenoxy herbicides was first the cohorts and the weak effect detected in most suggested by results from case–control studies of the positive studies, however, caution against in Umea, Sweden (Hardell & Sandström, 1979). a causal interpretation of the findings.] Exposure to TCDD in these and other commu- nity-based case–control studies is, however, not 2.6 Other cancers accurately estimated. An excess risk for soft- tissue sarcoma, based on a small number of Increased risks for several other malignant deaths, has been reported in the largest industrial neoplasms have been sporadically reported cohorts, specifically those of NIOSH and IARC among workers exposed to TCDD, and at (see Table  2.4, online). In both, the mortality Seveso. Most notable are risks for breast and ratios (SMRs) tended to be higher among the rectal cancers and myeloid leukaemia in Seveso, most exposed subcohorts. Incidence data for bladder cancer in the NIOSH and Dutch cohorts, soft-tissue sarcoma were generally not available. multiple myeloma in the NIOSH cohort, cancers A dose–response relationship, with estimated of the oral cavity and pharynx in the German exposure to TCDD, was found in a case–control cohorts, genital cancers in the Dutch cohort, and study nested in the IARC cohort; however, strong kidney cancer in the IARC cohort. [The avail- positive trends were also found with exposure able results are not fully consistent, and several estimates for 2,4-dichlorophenoxyacetic acid studies have not reported the results for each (2,4-D) and 2,4,5-trichlorophenoxyacetic acid individual cancer site.] (2,4,5-T). In Seveso, there were no cases of soft- tissue sarcoma in the most heavily contaminated Zones A and B. [Soft-tissue sarcomas are subject 2.7 Synthesis to serious misclassification on death certificates. Overall, the strongest evidence for the carci- Although it is unlikely that this occurs differ- nogenicity of TCDD is for all cancers combined, entially in the exposed and the referent popula- rather than for any specific site. The relative risk for tions, re-classification of a few cases would have all cancers combined in the most highly exposed important consequences on results based on and longer-latency subcohorts is around 1.4. In small numbers.] dose–response analyses, higher relative risks are observed for the groups with the highest meas- 2.5 Non-Hodgkin lymphoma ured and modelled exposure to TCDD. While this relative risk for all neoplasms does not appear An increased risk for non-Hodgkin lymphoma likely to be explained by confounding, particu- was found in most of the populations studied larly since dose–response was typically based in the four industrial cohort studies and in the on internal comparisons among workers of the Seveso population, although the relative risks same cohort, this possibility cannot be excluded. 10
  • 11. 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 The evidence for specific cancers is strongest subcutaneous injection in one study in hamsters. for lung cancer, soft-tissue sarcoma and non- TCDD produced tumours in both sexes of mice Hodgkin lymphoma, but confounding cannot be and rats, and in multiple organs and tissues. ruled out for lung cancer, while the findings on Oral administration of TCDD caused soft-tissue sarcoma are based on small numbers. increased incidences of thyroid follicular Several studies identified statistically significant adenomas and hepatocellular adenomas and increases in many cancers, but findings for other carcinomas in male and female mice, of alveolar/ cancers including major cancers are, overall, bronchiolar adenomas and carcinomas in male inconsistent between studies. It should be borne mice, and of histiocytic lymphomas and subcu- in mind that the general population is exposed taneous fibrosarcomas in female mice. In rats, to levels that are much lower than those experi- it caused increased incidences of hepatocellular enced by the industrial populations. adenomas in males and females, cholangiocarci- The Working Group did not review the epide- nomas and hepatocellular carcinomas in females, miological evidence of other PCDDs, PCDFs or lung cystic keratinizing epitheliomas and PCBs with a dioxin-like activity. squamous-cell carcinomas in females, adrenal gland (cortex) adenomas and squamous-cell carcinomas of the hard palate/nasal turbinates 3. Cancer in Experimental Animals in males and females, tongue squamous-cell carcinomas and thyroid follicular adenomas and 3.1 2,3,7,8-Tetrachlorodibenzo-para- carcinomas combined in males, subcutaneous fibromas in males and subcutaneous fibrosa- dioxin rcomas in females, and pituitary adenomas, Carcinogenicity studies with several strains uterine and oral mucosa (gingival) squamous-cell of rats, mice and Syrian hamsters treated with carcinomas and pancreatic adenomas and carci- 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) nomas combined in females (Van Miller et al., via the oral route (gavage or diet), by intra-peri- 1977; Kociba et al., 1978; Tóth et al., 1979, NTP, toneal injection, or by skin application have been 1982a, 2006a; Della Porta et al., 1987; Goodman reviewed in IARC Monograph Volume 69 (IARC, & Sauer, 1992; Hays et al., 1997, Yoshizawa et al., 1997). At the time, the review of the available 2005). Skin application or gavage caused benign data led to the conclusion that there is sufficient and malignant tumours of the skin in female mice evidence in experimental animals for the carci- including transgenic mice (NTP, 1982b; Wyde nogenicity of TCDD. The present Monograph et al., 2004). Hamsters that received TCDD by also evaluates relevant carcinogenicity studies in intraperitoneal or subcutaneous injection devel- TCDD-treated experimental animals that were oped squamous-cell carcinomas of the facial published since 1997. The results of adequately skin (Rao et al., 1988). Intraperitoneal injection conducted carcinogenicity studies are summa- caused increased incidence of hepatocellular rized below and in Table 3.1 and Table 3.2. adenomas and carcinomas in female mice and TCDD was tested for carcinogenicity by oral of lymphomas in male and female mice (Della administration (gavage or dose feed) in four Porta et al., 1987). studies in mice and six studies in rats, by skin Several studies in mice showed that admin- (topical) application in two studies in mice, by istration of TCDD with known carcinogens intraperitoneal injection in one study in mice, one enhanced the incidence of skin papillomas, lung study in rats and one study in hamsters and by adenomas, liver adenomas and hepatoblastomas. In female rats, TCDD co-administered with 11
  • 12. 12 Table 3.1 Carcinogenicity studies in mice exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Mouse, Swiss-Webster Skin application Data given for vehicle Purity 99.4% (M, F) TCDD applied to the skin of male controls, TCDD (alone)- and In the DMBA-TCDD experiment, the 99 or 104 wk (0.001 µg/animal) or females TCDD+DMBA-treated groups. lack of groups treated with DMBA alone, NTP (1982b) (0.005 µg/animal) per application Skin: precluded interpretation of the results. (equivalent to 0.15 µg/kg/wk and Fibrosarcomas– 0.75 µg/kg/wk respectively), 3 × / IARC MONOGRAPHS – 100F wk on alternate days in 0.1 ml 3/42 (7%), 6/28 (21%), 5/30 (17%) NS (M) acetone. Vehicle controls were (M); given 0.1 ml acetone 3 × /wk. 2/41 (5%), 8/27 (30%), 8/29 (27%) TCDD: P = 0.007 Groups of mice of either sex were (F) vs vehicle control also given a single application (F) of 50 µg DMBA one week before TCDD+DMBA: TCDD applications. This study P = 0.01 vs vehicle did not include a control group control (F) treated with DMBA alone Myxomas– Untreated controls: 15 mice/ group 0/41, 0/27, 1/29 (3%) (F) NS Vehicle-control: 45 animals/sex TCDD: 30 animals/sex TCDD + DMBA: 30 animals/sex Mouse, Tg.AC (F) Skin application Skin (squamous cell papillomas): Purity 99% 26 wk 0, 5, 17, 36, 76, 121, 166, 355, or 0/20, 1/20 (5%), 3/20 (15%), 11/20 P < 0.01 (15, 33, 52, Survival for TCDD-treated mice was Wyde et al. (2004) 760 ng/kg bw TCDD in acetone (55%), 10/20 (50%), 13/20 (65%), 71, 152, and 326 similar as in the controls, except for applied topically 3 × /wk for 26 17/20 (85%), 19/20 (95%), 20/20 ng/kg/d) lower survival rates observed in mice wk (equivalent to 0, 2.1, 7.3, 15, (100%) receiving 33 and 52 ng TCDD/kg (65 33, 52, 71, 152, 326 ng/kg/d) and 50%, respectively) vs controls (85%); 20 animals/group Skin (squamous cell carcinomas): however, this was thought not to be 0/20, 0/20, 1/20 (5%), 1/20 (5%), P < 0.01 (52, 71, treatment-related because the survival 3/20 (15%), 5/20 (25%), 8/20 (40%), 152, 326 ng/kg/d) rate of higher dose groups was similar to 14/20 (70%), 16/20 (80%) that of the control group. Keratoacanthomas: The response of TCDD-induced papilloma formation in the skin was 0/20, 0/20, 0/20, 0/20, 3/20 (15%), NS greater in mice exposed to TCDD 3/20 (15%), 2/20 (10%), 3/20 (15%), by the dermal route than by oral 1/20 (5%) administration (see gavage study by Wyde et al. (2004), below)
  • 13. Table 3.1 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Mouse, Swiss/H/Riop (M) Gavage Liver (tumours): Purity NR Lifetime 0, 0.007, 0.7, 7.0 µg/kg bw in 7/38 (18%), 13/44 (29%), 21/44 P < 0.01 (0.7 µg/ Tumour type NR Tóth et al. (1979) sunflower oil, once/wk for 1 yr. (48%), 13/43 (30%) kg) Average lifespan decreased considerably Controls received sunflower oil in the 7.0-µg/kg dose group (428 45 animals/group d) compared with controls (588 d). [Mortality-adjusted analysis was not performed and, therefore, the tumour incidence in the high-dose group may have been underestimated.] Mouse, B6C3F1 (M, F) Gavage Liver (hepatocellular adenomas): Purity 99.4% 104 wk 0.01, 0.05, 0.5 µg/kg bw 2x/wk Toxic hepatitis: NTP (1982a) (M) or 0.04, 0.2, 2.0 µg/kg bw 1/73, 5/49, 3/49, 44/50 (M); 7/73 (9%), 3/49 (6%), 5/49 (10%), P = 0.024 (trend, 2x/wk (F) as a suspension in 9:1 0/73, 1/50, 2/48, 34/47 (F) 10/50 (20%) (M); M) corn-oil/acetone at a volume of 0.05 ml/100 g bw, for 104 wk 2/73 (3%), 4/50 (8%), 4/48 (8%), Vehicle controls: 75 mice/sex 5/47 (11%) (F) Untreated controls: 25 mice/sex Liver (hepatocellular carcinomas): TCDD: 50 mice/sex 8/73 (11%), 9/49 (18%), 8/49 (16%), P = 0.002 (M) 17/50 (34%) (M); P = 0.002 (trend, M) 1/73 (1%), 2/50 (4%), 2/48 (4%), P = 0.014 (F) 6/47 (13%) (F) P = 0.008 (trend, F) Liver (hepatocellular adenomas or carcinomas): 15/73 (20%), 12/49 (24%), 13/49 P < 0.001 (high- (26%), 27/50 (54%) (M); dose M) P < 0.001 (trend, M) 3/73, (4%), 6/50 (12%), 3/48 (6%), P < 0.005 (high- 11/47 (23%) (F) dose F) P < 0.002 (trend, F) 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 13
  • 14. 14 Table 3.1 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Mouse, B6C3F1 (M, F) Thyroid (follicular adenomas): 104 wk NTP (1982a) 0/69, 3/48 (6%), 0/48, 0/49 (M); P = 0.008 (trend Contd. M) 0/69, 3/50 (6%), 1/47 (2%), 5/46 P = 0.009 (high- (11%) (F) dose, F) IARC MONOGRAPHS – 100F P = 0.016 (trend, F) Lung (alveolar/bronchiolar adenomas): 7/71 (10%), 2/48 (4%), 4/48 (8%), P = 0.006 (trend, 11/50 (22%) (M) M) Lung (alveolar/bronchiolar adenomas or carcinomas): 10/71 (14%), 2/48 (4%), 4/48 (8%), P = 0.004 (trend, 13/50 (26%) (M) M) Subcutaneous tissue (fibrosarcomas): 1/74 (1%), 1/50 (2%), 1/48 (2%), P = 0.032 (high- 5/47 (11%) (F) dose, F) P = 0.007 (trend, F) Lymphoid tissue (histiocytic lymphomas): 9/74 (12%), 4/50 (8%), 8/48 (17%), P = 0.016 (high- 14/47 (30%) (F) dose, F) P = 0.003 (trend, F)
  • 15. Table 3.1 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Mouse, C57BL/6J x C3Hf, Gavage Hepatocellular adenomas: Laboratory grade; purity NR (M, F) 0, 2.5, 5.0 µg/kg bw in 0.01 ml/ Treatment with both doses caused a 110 wk kg bw corn-oil containing 1.2% marked depression in mean body weight Della Porta et al. (1987) acetone, once/wk for 52 wk, (no significance given) and reduced followed until 104 wk. Controls survival (P < 0.001) in male and female given corn-oil/acetone (~99:1) 10/43, 11/51, 10/50 (M); P < 0.001, for mice. once/wk for 52 wk. 2/49, 4/42, 11/48 (F) fatal tumour test Male mice, treated once by mistake At 31–39 wk, 41 M and 32 F in (M); P < 0.01, for with a dose of 25 µg/kg TCDD had an the 2.5-µg/kg bw group were fatal tumour test increased mortality shortly after the 2.5- erroneously treated once with (F); P < 0.001 for µg/kg treatment. The incidence of other a dose of 25 µg/kg TCDD. The incidental tumour tumour types were uniformly low in treatment of these mice was test (F) treated and control groups of both sexes, interrupted for five wk and then Hepatocellular carcinomas: and were not treatment related. continued until wk 57, as for the other treated mice. At the end of treatment, all groups were kept under observation until 110 wk. 45–55 animals/group 5/43 (12%), 15/51 (29%), 33/50 P < 0.005, for (66%) (M); both fatal and 1/49 (2%), 12/42 (29%), 9/48 (19%) incidental tumour (F) test (M, F) Mouse, Tg.AC (F) Gavage Skin (squamous cell papillomas): Purity 99% 26 wk 0, 105, 450, or 1 250 ng TCDD/kg 1/20 (5%), 2/20 (10%), 3/20 (15%), P < 0.01 (high- Wyde et al. (2004) bw, 5 d/wk, for 26 wk (equivalent 11/20 (55%) dose) to 0, 75, 321, 893 ng/kg/d, 5 d/wk) 20 animals/group Skin (squamous cell carcinomas): 0/20, 0/20, 1/20 (5%), 13/20 (65%) P < 0.01 (high- dose) Keratoacanthomas: 0/20, 0/20, 0/20, 1/20 (5%) NS 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 15
  • 16. 16 Table 3.1 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Mouse, immature B6C3 Intraperitoneal injection B6C3 mice: Treatment with 30 and 60 µg/kg bw and B6C (M, F) 0, 1, 30, 60 µg/kg bw in 0.01 ml/ TCDD increased mortality in both 78 wk kg bw corn-oil vehicle containing Hepatocellular adenomas– hybrids (no statistical analysis). Della Porta et al. (1987) 1.2% acetone starting at 10 days Animals that died within 13 wk of age of age, once/wk for 5 wk and 6/45 (13%), 5/55 (9%), 5/52 (10%), P < 0.043 (trend, were excluded from histopathological observed until 78 wk of age. 11/43 (26%) (M); M) evaluation and the statistical analyses. Controls given corn-oil/acetone 0/42, 1/57 (2%), 1/48 (2%), 5/56 P < 0.014 (trend, F) The 15 thymic lymphomas were found IARC MONOGRAPHS – 100F (~99:1) (9%) (F) in animals dying between 16 and 41 wk B6C3: 151–186; 97 controls Hepatocellular carcinomas– of age and most of them (11 out of 15) B6C: 89–138; 105 controls were observed within 26 wk of age. Non- 3/45 (7%), 1/55 (2%), 9/52 (17%), P < 0.001 (60 µg/ thymic lymphomas involved mesenteric 14/43 (32%) (M); kg, M) lymph nodes, Peycr patches, and the P = 0.002 (trend, spleen, with secondary involvement of M) multiple organs. 0/42, 0/57, 1/48 (2%), 1/57 (2%) (F) Thymic lymphomas– 0/45, 0/55, 1/52 (2%), 2/43 (5%) (M); 0/42, 0/57, 0/48, 5/57 (9%) (F) P < 0.05 (60 µg/ kg, F) Non thymic lymphomas– 1/45 (2%), 2/55 (4%), 1/52 (2%), 1/43 (2%) (M); 0/42, 1/57 (2%), 8/48 (17%), 3/57 P < 0.05 (30 µg/ (5%) (F) kg, F)
  • 17. Table 3.1 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Mouse, immature B6C3 B6C mice: and B6C (M, F) 78 wk Hepatocellular adenomas– Della Porta et al. (1987) Contd. 1/32 (3%), 2/54 (4%), 1/27 (4%), NS 0/30 (M) Thymic lymphomas– 0/32, 0/54, 2/27 (7%), 2/30 (7%) P < 0.05 (trend, (M); M, F) 0/48, 0/57, 1/39 (3%), 2/38 (5%) (F) Non thymic lymphomas– 0/32, 0/54, 1/27 (4%), 2/30 (7%) P < 0.05 (trend, (M); M, F) 1/48 (2%), 3/57 (5%), 5/39 (13%), 3/38 (8%) (F) bw, body weight; d, day or days; DMBA, 7,12-dimethylbenz[a]anthracene; F, female; M, male; NR, not reported; NS, not significant; vs, versus; wk, week or weeks; yr, year or years 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 17
  • 18. 18 Table 3.2 Carcinogenicity studies in rats and hamsters exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Rat, Osborne-Mendel Gavage Liver neoplastic nodules (adenomas): Purity 99.4% (M, F) 0, 0.01, 0.05, 0.5 µg/kg bw 0/74, 0/50, 0/50, 3/50 (M); P < 0.005 (trend, M) Increased incidence of 104 wk twice/wk as a suspension 5/75 (7%), 1/49 (2%), 3/50 (6%), 12/49 P = 0.006 (high-dose F) hepatotoxicity occurred in the NTP (1982a) in 9:1 corn-oil/acetone at a (24%) (F) P < 0.001 (trend, F) high-dose male (0/50, 0/74, volume of 0.05 ml/100 g bw, 1/50, 0/50, 14/50 and female Liver neoplastic nodules and for 104 wk (0/49, 0/75, 0/49, 1/50, 32/49) hepatocellular carcinomas: IARC MONOGRAPHS – 100F Vehicle controls received 9:1 rats. One high dose-treated corn-oil/acetone 0/74, 0/50, 0/50, 3/50 (2%) (M); P < 0.005 (trend, M) male developed a hepatocellular Vehicle controls: 75 rats/sex 5/75 (7%), 1/49 (2%), 3/50 (6%), 14/49 P = 0.001 (high-dose F) carcinoma. Untreated controls: 25 rats/ (29%) (F) P < 0.001 (trend, F) sex Thyroid: TCDD: 50 rats/sex Follicular adenomas: 1/69 (1%), 5/48 (10%), 6/50 (12%), 10/50 P = 0.042 (low-dose), 0.021 (20%) (M); (mid-dose), 0.001 (high- 3/73 (4%), 2/45 (4%), 1/49 (2%), 6/47 (13%) dose M) (F) P < 0.006 (trend, M) Follicular adenomas/carcinomas: 1/69 (1%), 5/48 (10%), 8/50 (16%), 11/50 P = 0.042 (low-dose, M), (22%) (M); P = 0.004 (mid-dose, M), 5/73 (7%), 2/45 (4%), 1/49 (2%), 6/47 (13%) P < 0.001 (high-dose M) (F) P < 0.005 (trend, M) Adrenal: Cortical adenomas– 6/72 (8%), 9/50 (18%), 12/49 (24%), 9/49 P = 0.015 (mid-dose M) (18%) (M); 11/73 (15%), 8/49 (16%), 4/49 (8%), 14/46 P = 0.019 (trend, F) (30%) (F) Subcutaneous tissue: Fibromas– 3/75 (4%), 1/50 (2%), 3/50 (6%), 7/50 (14%) P = 0.048 (high-dose M) (M) P < 0.01 (trend, M) Fibrosarcomas– 0/75, 2/50 (4%), 3/50 (6%), 4/49 (8%) (F) P = 0.023 (high-dose F) Pituitary (adenomas): 1/66 (1%), 5/47 (8%), 2/44 (4%), 3/43 (7%) P = 0.044 (low-dose F) (F)
  • 19. Table 3.2 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Rat, Harlan Sprague- Gavage Liver: Purity 98% Dawley (F) 0, 3, 10, 22, 46, or 100 ng/kg Survival of dosed groups was 105 wk bw, 5 d/wk, for up to 105 wk similar to that of the vehicle- NTP (2006a), Controls given corn-oil with control group. Mean body Yoshizawa et al. (2005) acetone (91:1) weights of the 22-, 46-, 100-ng/ A stop-exposure group of 50 kg core study and stop-exposure females received 100 ng/kg Hepatocellular adenomas– groups were less than those of TCDD in corn-oil/acetone 0/53, 0/54, 0/53, 0/53, 1/53 (2%), 13/53 P < 0.001 (100 ng/kg) the vehicle-control group (91:1) for 30 wk and then the (25%), 2/50 (4%) P < 0.001 (trend) vehicle for the remainder of Cholangiocarcinomas– the study 8–10 animals/group were 0/53, 0/54, 0/53, 1/53, (2%) 4/53 (8%), P < 0.057 (46 ng/kg). evaluated at 14, 31 or 53 wk; 25/53 (47%), 2/50 (4%) P < 0.001 (100 ng/kg) 81–82 animals/group P < 0.001 (trend) Lung (cystic keratinizing epitheliomas): 0/53, 0/54, 0/53, 0/52, 0/53, 9/52 (17%), P = 0.002 (100 ng/kg) 0/50 P < 0.001 (trend) Oral mucosa (gingiva) (squamous cell carcinomas): 1/53 (2%), 2/54 (4%), 1/53 (2%), 0/53, 4/53 P = 0.007 (100 ng/kg) (8%), 10/53 (19%), 5/50 (10%) P < 0.001 (trend) Uterus (squamous cell carcinomas): 0/53, 0/54, 0/53, 0/53, 5/53 (9%), 0/53, 2/50 P = 0.032 (46 ng/kg) (4%) Pancreas (acinar adenomas or carcinomas): 0/51, 0/54, 0/52, 0/53, 0/52, 3/51 (6%) P < 0.001 (trend) 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 19
  • 20. 20 Table 3.2 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Rats, Sprague-Dawley Diet Total tumours: All animals given 50, 500 (M) Rats were placed on diet Diet (ppt) and 1 000 ppb died between 95 wk containing 0, 1, 5, 50, 500 a the second and fourth wk on 0/10, 0/10, 5/10 (50%)a, 3/10 (30%), 4/10 [P = 0.0325] Van Miller et al. ppt or 1, 5, 50, 500, or 1 000 (40%) study. At the end of the study, (1977) ppb suspended in acetone 4/10, 8/10, 6/10, 6/10 and 5/10 Diet (ppb) and dissolved in corn rats were alive in the 0, 1, 5, 1 ppb–4/10 (40%) oil, for 78 wk after which 50 and 500 ppt treated rats, IARC MONOGRAPHS – 100F b feeding with basal diet was 5 ppb–7/10 (70%)b [P = 0.0031] respectively. No animals were continued. A control group alive in the 1- and 5-ppb groups. was maintained on the basal Food intake in these groups was diet. At 65 wk, laparotomies significantly less than that of the were performed on all Neoplasms included controls and the animals had animals and biopsies taken 5 ppt: 1 ear duct carcinoma, 1 acute toxicity. Weight gain was from all tumours observed. lymphocytic leukaemia, 1 renal significantly different from that Surviving rats were adenocarcinoma, 1 malignant of the controls only in the 5-ppb sacrificed at 95 wk. histiocytoma (peritoneal), 1 group. Neoplasms of the liver 10 animals/group angiosarcoma (skin), 1 Leydig-cell occurred only in animals fed 1 adenoma (testes) or 5 ppb TCDD. 50 ppt: 1 fibrosarcoma (muscle), 1 squamous cell tumour (skin), 1 astrocytoma (brain) 500 ppt: 1 fibroma (striated muscle), 1 carcinoma (skin), 1 adenocarcinoma (kidney), 1 sclerosing seminoma (testes) 1 ppb–1 cholangiocarcinoma, 1 angiosarcoma (skin), 1 glioblastoma (brain), 2 malignant histiocytomas (peritoneal) 5 ppb–4 squamous cell tumours (lung), 4 neoplastic nodules (liver), 2 cholangiocarcinomas
  • 21. Table 3.2 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Rat, Sprague-Dawley Diet feed Liver: Purity > 99% (Spartan substrain) 0, 0.001, 0.01, 0.1 µg/kg Reduced survivaI was observed Hyperplastic nodules– (M, F) bw/d (equivalent to 0, 22, in high-dose females and in 24 mo 210, 2 200, ppt) in the diet. 6/85 (7%), 0/50, 3/50 (6%), 2/50 (4%) (M); mid- and high-dose males. Kociba et al. (1978), Control groups received a Mean body weights of high-dose Hays et al. (1997), basal diet containing the 8/86 (9%), 3/50 (6%), 18/50 (36%), 23/49 P < 0.05; 0.01 and 0.1µg/ males and mid- and high-dose Goodman & Sauer vehicle acetone alone. (47%) (F) kg (F) femaIes were less than those (1992) Controls: 86 animals/group/ Hepatocellular carcinomas– of the controls throughout sex 2/85, 0/50, 0/50, 1/50 (2%) (M); the major portion of the Treated: 50 animals/group/ study. Decreased incidence of sex 1/86 (1%), 0/50, 2/50 (4%), 11/49 (22%) (F) P < 0.05; 0.1 µg/kg (F) tumours of the pituitary, uterus, mammary glands, pancreas, Hard palate/nasal turbinates (squamous adrenal gland occurred in cell carcinomas): treated rats. 0/85, 0/50, 0/50, 4/50 (8%) (M); P < 0.05; 0.1 µg/kg (M, F) 0/86, 0/50, 1/50 (2%), 4/49 (8%) (F) Tongue (squamous cell carcinomas): 0/85, 1/50 (2%), 1/50 (2%), 3/50 (6%) (M); P < 0.05; 0.1 and 0.01µg/ kg (M) 1/86 (1%), 0/50, 0/50, 2/49 (4%) (F) Lung (keratinizing squamous cell carcinomas): 0/85, 0/50, 0/50, 1/50 (2%) (M); 0/86, 0/50, 0/50, 7/50 (14%) (F) P < 0.05; 0.1 µg/kg (F) 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 21
  • 22. 22 Table 3.2 (continued) Species, strain (sex) Dosing regimen, Results Significance Comments Duration Animals/group at start Incidence and/or multiplicity of Reference tumours (%) Hamster, Syrian Intraperitoneal injection Skin (squamous-cell carcinomas): Purity NR Golden (M) 0, 100 µg/kg bw TCDD in Dioxane alone–0/12 6/24 animals injected with 100 12–13 mo dioxane as 6 injections at 4 µg/kg died before completion of Rao et al. (1988) wk intervals (once every 4 the 6-dose schedule of TCDD wk). An additional group due to intestinal adhesions received 2 injections of 100 100 µg/kg TCDD, 6 doses–4/18 (21%) [NS] along with obstruction and µg/kg TCDD. Controls 100 µg/kg TCDD, 2 doses–0/20 peritonitis IARC MONOGRAPHS – 100F received corresponding amounts of dioxane alone. 12–24 animals/group Subcutaneous injection Skin (squamous cell carcinomas): Purity NR 0, 50 or 100 µg/kg bw TCDD Dioxane alone–0/10 4/17 injected with 100 µg/ in dioxane as 6 injections at kg died before completion of 4-wk intervals (once every the 6-dose schedule of TCDD 4 wk). Controls received due to marked pulmonary and corresponding amounts of hepatic congestion. Tumours dioxane alone. 50 µg/kg TCDD–0/10 [NS] were moderately differentiated 10 or 17 animals/group 100 µg/kg TCDD–3/14 (21%) squamous-cell carcinomas that developed exclusively in the facial skin d, day or days; F, female; M, male; mo, month or months; NR, not reported; NS, not significant; ppb, part per billion; ppt, part per trillion; wk, week or weeks
  • 23. Table 3.3 Studies on 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) administered with known carcinogens or modifying factors Species, strain (sex), Known carcinogen Route of Interval Dose and frequency Route of Tumour duration, reference administration (times per week/number of weeks) administration promotion Liver tumour promotion Han/Wistar rats (F) 30 mg/kg bw NDEA i.p. 35 d 170 μg/kg bw TCDD/weekly/20 wk s.c. + Duration (NR) Starting 5 wk after PH Purity > 99% Viluksela et al. (2000) Mammary gland tumour promotion SD rats (F) 30 mg/kg bw DMBA in oral N/A 1 μg/kg bw TCDD in sesame oil in oral + Brown et al. (1998) sesame oil (to 50-d-old pregnant F on Day 15 p.c. offspring) Ovarian tumour promotion SD rats (F) 175 mg/kg bw NDEA i.p. 14 d 1.75 µg/kg bw TCDD in corn oil, oral + Davis et al. (2000) in saline twice/wk for 60 wk 175 mg/kg bw NDEA i.p. 18 wk 1.75 µg/kg bw TCDD in corn oil, oral + in saline twice/wk for 30 wk followed by vehicle for 16 wk bw, body weight; d, day or days; DMBA, 7,12-dimethylbenz[a]anthracene; F, female; i.p., intraperitoneal injection; M, male; mo, month or months; N/A, not applicable; NDEA, N-nitrosodiethylamine; NR, not reported; p.c., post-conception; PH, partial hepatectomy; s.c., subcutaneous injection; SD, Sprague-Dawley; wk, week or weeks 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, PCB 126 23
  • 24. 24 Table 3.4 Carcinogenicity and initiation-promotion studies in experimental animals exposed to 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) and 3,3′,4,4′,5-pentachlorobiphenyl (PCB 126) Species, strain (sex) Dosing regimen, Incidence and/or mutiplicity of Significance Comments Duration Animals/group at start tumours (%) Reference PeCDF Rats, Harlan (F) Groups of 81 female rats were Liver: Purity > 97%. 105 wk given 0, 6, 20, 44, 92, or 200 Hepatocellular adenomas– Survival of dosed groups was NTP (2006b) ng PeCDF/kg bw in corn-oil/ similar to that of the vehicle- 1/53 (2%), 0/53, 1/53 (2%), 0/52, 2/53 P = 0.006 (trend) acetone (99:1) by gavage, 5 d control group. IARC MONOGRAPHS – 100F (4%), 4/53 (8%), 1/50 (2%) per wk, for up to 105 wk. A stop-exposure group of 50 Cholangiocarcinomas– female rats was administered 0/53, 0/53, 0/53, 1/52 (2%), 1/53 (2%), P = 0.036 (trend) 200 ng/kg PeCDF in corn-oil/ 2/53 (4%), 0/50 acetone (99:1) by gavage for Mammary gland (carcinomas): 30 wk and then the vehicle for the remainder of the study. 5/53 (9%), *12/53 (23%), **13/53 (24%), *P = 0.036 8–10 rats per group were 2/53 (4%), 5/53 (9%), 3/53 (6%) **P = 0.021 evaluated at 14, 31, and 53 wk. P = 0.021 (trend, Controls received corn-oil. negative) Mice, HRS/J hairless (F) Skin application of 5 µmol Skin (papillomas): 21 wk MNNG in 50 µL acetone 1/19 (5%); 9/19 (47%); 11/18 (61%); 8/18 P < 0.05 (all PeCDF- Hébert et al. (1990) followed one wk later by (44%) treated groups) application with 0 (control), 25, 50 or 100 ng PeCDF in 25 µL acetone twice a wk for 20 wk 20 animals/group